UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z
Number of items: 561.

A

Adams, MJ; Cardigan, RA; Marchant, WA; Grocott, MPW; Mythen, MG; Mutch, M; Purdy, G; (2002) Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass. J CARDIOTHOR VASC AN , 16 (1) 59 - 63. 10.1053/jcan.2002.29677.

Ala, A; Standish, R; Khan, K; Hillan, K; Dhillon, A; Hodgson, H; (2002) Podoplanin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) localisation in primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC). Journal of Hepatology , 36 501-.

Ala, A; Standish, R; Khan, K; Stubbs, M; Hillan, K; Dhillon, AP; Hodgson, HJF; (2002) Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and podoplanin localisation in primary sclerosing cholangitis (PSC) & primary biliary cirrhosis (PBC). Gut , 50 202-.

Ala, A; Standish, R; Khan, K; Stubbs, M; Hillan, K; Dhillon, AP; Hodgson, HJF; (2002) Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and podoplanin localisation in primary sclerosing cholangitis (PSC) & primary biliary cirrhosis (PBC). GUT , 50 A56 - A56.

Aligianis, IA; Forshew, T; Johnson, S; Michaelides, M; Johnson, CA; Trembath, RC; Hunt, DM; (2002) Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2). J MED GENET , 39 (9) 656 - 660.

Allcock, RJN; Atrazhev, AM; Beck, S; de Jong, PJ; Elliott, JF; Forbes, S; Halls, K; (2002) The MHC haplotype project: A resource for HLA-linked association studies. TISSUE ANTIGENS , 59 (6) 520 - 521.

Alley, MC; Hollingshead, MG; Pacula-Cox, CM; Waud, WR; Hartley, JA; Howard, PW; Gregson, SJ; (2002) Efficacy evaluations of SJG-136 (NSC 694501), a novel pyrrolobenzodiazepine dimer with broad spectrum antitumor activity. In: (pp. 315-).

Ancliff, PJ; Gale, RE; Somerville, TC; Kwaja, A; Liesner, R; Hann, IM; Linch, DC; (2002) Complete inhibition of neutrophil elastase fails to correct the in vitro phenotype of severe congenital neutropenia. In: BLOOD. (pp. 243A - 243A). AMER SOC HEMATOLOGY

Ancliff, PJ; Gale, RE; Watts, MJ; Liesner, R; Hann, IM; Strobel, S; Linch, DC; (2002) Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. Blood , 100 (2) pp. 707-709. 10.1182/blood-2002-01-0060. Green open access
file

Ancliff, PJ; Gale, RE; Watts, MJ; Liesner, R; Hann, IM; Strobel, S; Linch, DC; (2002) Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. BLOOD , 100 (2) 707 - 709.

Angeli, I; James, C; Morgan, P; Sharpe, P; (2002) Misexpression of Genes in Mouse Tooth Germs Using In Vitro Electroporation. Connective Tissue Research , 43 (2) pp. 180-185. 10.1080/713713525.

Angeli, I; James, CT; Morgan, PJ; Sharpe, PT; (2002) Misexpression of Genes in Mouse Tooth Germs Using In Vitro Electroporation. Connective Tissue Research , 43 (2-3) pp. 180-185. 10.1080/03008200290000943.

Ansell, SM; Arendt, BK; Grote, DM; Jelinek, DF; Novak, AJ; Wellik, LE; Remstein, ED; (2002) Inhibition of survivin expression suppresses the growth of transformed large cell non-Hodgkin lymphoma. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 352A-352A). AMER SOC HEMATOLOGY

Arcaro, A; Khanzada, UK; Vanhaesebroeck, B; Tetley, TD; Waterfield, MD; Seckl, MJ; (2002) Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation. EMBO JOURNAL , 21 (19) pp. 5097-5108. 10.1093/emboj/cdf512.

Ardeshna, K; Smith, P; Norton, A; Hancock, B; Hoskin, PJ; (2002) The long term impact of a watch and wait policy vs immediate systemic treatment for asymptomatic advanced stage indolent non Hodgkin's lymphoma: results of a British National Lymphoma randomized trial. In: (pp. 76-).

Ardeshna, KM; Pizzey, AR; Walker, SJ; Devereux, S; Khwaja, A; (2002) The upregulation of CC chemokine receptor 7 and the increased migration of maturing dendritic cells to macrophage inflammatory protein 3 beta and secondary lymphoid chemokine is mediated by the p38 stress-activated protein kinase pathway. BRIT J HAEMATOL , 119 (3) 826 - 829.

Arkenau, H-T; Widjaja, A; (2002) [A rare case of cholestasis and macrohematuria in a 52-year-old patient]. Med Klin (Munich) , 97 (8) pp. 480-483.

Arkenau, HT; Stichtenoth, DO; Frölich, JC; Manns, MP; Böker, KHW; (2002) Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation. Z Gastroenterol , 40 (11) pp. 907-913. 10.1055/s-2002-35413.

Arkenau, HT; Widjaja, A; (2002) An unusual case of cholestasis and makrohematuria in a 52-year-old patient. Medizinische Klinik , 97 (8) pp. 480-483. 10.1007/s00063-002-1183-3.

Asher, D; Atterbury, C; Chapman, C; Cohen, H; Jones, H; Love, E; (2002) The 2000/2001 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Atalay, G; Biganzoli, L; Renard, F; Paridaens, R; Batter, V; Coleman, R; Piccart, M; (2002) Clinical outcome of breast cancer patients with liver metastases in the anthracycline-taxane era. Breast Cancer Research and Treatment , 76 138-.

Attygalle, A; Al-Jehani, R; Diss, TC; Munson, P; Liu, HX; Du, MQ; Isaacson, PG; (2002) Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. BLOOD , 99 (2) pp. 627-633. 10.1182/blood.V99.2.627.

Attygalle, AD; Al-Jehani, R; Diss, TC; Munson, P; Liu, H; Du, MQ; Isaacson, PG; (2002) Characterisation of T-cells expressing CD10 in angioimmunoblastic T-cell lymphoma. LABORATORY INVESTIGATION , 82 (1) 229A-230A.

Attygalle, AD; Al-Jehani, R; Diss, TC; Munson, P; Liu, H; Du, MQ; Isaacson, PG; (2002) Characterisation of T-cells expressing CD10 in angioimmunoblastic T-cell lymphoma. MODERN PATHOLOGY , 15 (1) 229A-230A.

Avivi, I; Bacon, CM; Obermann, EC; Quian, WD; Smith, P; Linch, DC; Dogan, A; (2002) Histological and clinical prognostic factors in follicular lymphoma: Proposal for a prognostic model. In: BLOOD. (pp. 37A - 37A). AMER SOC HEMATOLOGY

Avivi, I; Kyriakou, C; Kottaridis, PD; Chakrabarti, S; Goldstone, AH; Mackinnon, S; (2002) Neurological complications post low intensity bone marrow transplantation. In: BLOOD. (pp. 412A - 412A). AMER SOC HEMATOLOGY

B

Baraldi, PG; Romagnoli, R; Guadix, AE; de las Infantas, MJP; Gallo, MA; Espinosa, A; Martinez, A; (2002) Design, synthesis, and biological activity of hybrid compounds between uramustine and DNA minor groove binder distamycin A. J MED CHEM , 45 (17) 3630 - 3638. 10.1021/jm011113b.

Baraldi, PG; Romagnoli, R; Pavani, MG; Nunez, MD; Bingham, JP; Hartley, JA; (2002) Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: Synthesis and antitumour activity. BIOORGAN MED CHEM , 10 (5) 1611 - 1618.

Barker, KT; Bevan, S; Wang, R; Lu, YJ; Flanagan, AM; Bridge, JA; Fisher, C; (2002) Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. BRIT J CANCER , 87 (4) 446 - 448. 10.1038/sj.bjc.6600502.

Barnouin, K; Dubuisson, ML; Child, ES; Fernandez de Mattos, S; Glassford, J; Medema, RH; Mann, DJ; (2002) H202 induces a transient multi-phase cell cycle arrest in mouse fibroblasts through modulating cyclin D and p21Cip1 expression. Journal of Biological Chemistry , 277 (16) pp. 13761-13770. Gold open access

Baselga, J; Rischin, D; Ranson, M; Calvert, H; Raymond, E; Kieback, DG; Kaye, SB; (2002) Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. J CLIN ONCOL , 20 (21) 4292 - 4302. 10.1200/JCO.2002.03.100.

Bates, AW; (2002) Conjoined twins in the 16th century. TWIN RES , 5 (6) 521 - 528.

Bates, AW; (2002) Documentary evidence for conjoined twins in the sixteenth century. AM J MED GENET , 112 (4) 430 - 431. 10.1002/ajmg.10749.

Bates, AW; Baithun, SI; (2002) Secondary solid neoplasms of the prostate: a clinico-pathological series of 51 cases. VIRCHOWS ARCH , 440 (4) 392 - 396. 10.1007/s004280100505.

Bates, AW; Baithun, SI; (2002) Secondary tumours of the penis. J ROY SOC MED , 95 (3) 162 - 163.

Bates, AW; Baithun, SI; (2002) The significance of secondary neoplasms of the urinary and male genital tract. VIRCHOWS ARCH , 440 (6) 640 - 647. 10.1007/s00428-001-0549-x.

Bates, AW; Hall, CM; Morgan, H; Rosser, EM; Scheimberg, I; (2002) Lethal acrofacial dysostosis, pre- and post-axial defects of the hands, and bilateral renal agenesis. CLIN DYSMORPHOL , 11 (1) 63 - 66.

Batey, MA; Wright, JG; Azzabi, A; Newell, DR; Lind, MJ; Calvert, AH; Boddy, AV; (2002) Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF). EUR J CANCER , 38 (8) 1081 - 1089.

Beauregard, DA; Pedley, RB; Hill, SA; Brindle, KM; (2002) Differential sensitivity of two adenocarcinoma xenografts to the anti-vascular drugs combretastatin A4 phosphate and 5,6-dimethylxanthenone-4-acetic acid, assessed using MRI and MRS. NMR BIOMED , 15 (2) 99 - 105. 10.1002/nbm.723.

Bellan, C; Lazzi, S; Zazzi, M; Lalinga, AV; Palummo, N; Galieni, P; Marafioti, T; (2002) Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells? Diagn Mol Pathol , 11 (1) pp. 2-8.

Bentzen, SM; Saunders, MI; Dische, S; (2002) From CHART to CHARTWEL in non-small cell lung cancer: Clinical radiobiological modelling of the expected change in outcome. Clinical Oncology , 14 (5) pp. 372-381.

Bernardi, R; Grisendi, S; Salomoni, P; Scaglioni, PP; Pandolfi, PP; (2002) The promyelocytic leukemia protein, PML, localizes to the nucleolus after DNA damage, interacts with Mdm2 and promotes p53 stability. In: BLOOD. (pp. 31A - 32A). AMER SOC HEMATOLOGY

Bernassola, F; Salomoni, P; Di Como, C; Pagano, N; Melino, G; Pandolfi, PP; (2002) PML enhances p73 transcriptional activity and biological functions by preventing its proteasome-dependent degradation. In: BLOOD. (pp. 177B - 177B). AMER SOC HEMATOLOGY

Bernstein, H-G; Heinemann, A; Krell, D; Mawrin, C; Bielau, H; Danos, P; Diekmann, S; (2002) Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients. Ann N Y Acad Sci , 973 pp. 91-93.

Best, JL; Ganiatsas, S; Agarwal, S; Changou, A; Salomoni, P; Shirihai, O; Meluh, PB; (2002) SUMO-1 protease-1 regulates gene transcription through PML. MOL CELL , 10 (4) 843 - 855.

Biganzoli, L; Cufer, T; Bruning, P; Coleman, R; Duchateau, L; Calvert, AH; Gamucci, T; (2002) Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 multicenter phase III trial. J CLIN ONCOL , 20 (14) 3114 - 3121. 10.1200/JCO.2002.11.005.

Boddy, AV; Todd, R; Verrill, M; Sludden, J; Fishwick, K; Robson, L; Cassidy, J; (2002) Pharmacological study of CT-2103 (XyotaxTM), a poly(L-glutamic acid)-paclitaxel conjugate administered every 3 weeks or every 2 weeks in a phase I study. European Journal of Cancer , 38 98-.

Bogunia-Kubik, K; Natarajan, P; Madrigal, JA; Cohen, SBA; (2002) The effect of cord blood sera on CD69 expression. IMMUNOL LETT , 84 (1) pp. 77-80.

Bomanji, JB; Syed, R; Brock, C; Jankowska, P; Dogan, A; Costa, DC; Ell, PJ; (2002) Challenging cases and diagnostic dilemmas: case 2. Pitfalls of positron emission tomography for assessing residual mediastinal mass after chemotherapy for Hodgkin's disease. J Clin Oncol , 20 (15) pp. 3347-3349. 10.1200/JCO.2002.20.15.3347.

Boshoff, C; (2002) Kaposi's sarcoma biology. IUBMB LIFE , 53 (4-5) 259 - 261. 10.1080/15216540290099034.

Boshoff, C; (2002) Kaposi's sarcoma biology. IUBMB Life , 53 (4-5) pp. 259-261. 10.1080/15216540212645.

Boshoff, C; (2002) Targets for treatment: Lessons from aids-related malignancies. BRIT J CANCER , 86 S11 - S11.

Boshoff, C; Weiss, R; (2002) Aids-related malignancies. NAT REV CANCER , 2 (5) 373 - 382. 10.1038/nrc797.

Bowen, RL; Francis, RJ; Green, AJ; Baig, S; Knell, V; Buscombe, JR; Hilson, AJW; (2002) How accurately can the oncologist report FDG-PET tumour response using the ADAC vertex plus dual-headed gamma camera? British Journal of Cancer , 86 S102-S102.

Bowen, RL; Francis, RJ; Green, AJ; Baig, S; Knell, V; Buscombe, JR; Hilson, AJW; (2002) How accurately can the oncologist report FDG-PET tumour response using the ADAC vertex plus dual-headed gamma camera? BRIT J CANCER , 86 S102 - S102.

Branson, K; Chopra, R; Kottaridis, PD; McQuaker, G; Parker, A; Schey, S; Chakraverty, RK; (2002) Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies. Journal of Clinical Oncology , 20 (19) pp. 4022-4031. 10.1200/JCO.2002.11.088.

Branson, K; Chopra, R; Kottaridis, PD; McQuaker, G; Parker, A; Schey, S; Chakraverty, RK; (2002) Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies. J CLIN ONCOL , 20 (19) 4022 - 4031. 10.1200/JCO.2002.11.088.

Braybrooke, JP; Slade, A; Gibson, R; Deplanque, G; Madhusudan, S; Makris, A; (2002) Phase one study of MetXia-P450 gene therapy for patients with advanced breast cancer or melanoma. In: (pp. 22a-).

Brett, BT; Smith, SC; Bouvier, CV; Michaeli, D; Hochhauser, D; Davidson, BR; Kurzawinski, TR; (2002) Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer. J CLIN ONCOL , 20 (20) 4225 - 4231. 10.1200/JCO.2002.11.151.

Broceño, C; Wilkie, S; Mittnacht, S; (2002) RB activation defect in tumor cell lines. Proc Natl Acad Sci U S A , 99 (22) pp. 14200-14205. 10.1073/pnas.212519499.

Brock, CS; Lee, SM; (2002) Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer. EUROPEAN RESPIRATORY JOURNAL , 19 (3) pp. 557-570. 10.1183/09031936.02.00293002.

Brooks, LA; Sullivan, A; O'Nions, J; Bell, A; Dunne, B; Tidy, JA; Evans, DJ; (2002) E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia. BRITISH JOURNAL OF CANCER , 86 (2) pp. 263-268. 10.1038/sj/bjc/6600033.

Brown, RS; Edwards, J; Bartlett, JW; Jones, C; Dogan, A; (2002) Routine acid decalcification of bone marrow samples can preserve DNA for FISH and CGH studies in metastatic prostate cancer. Journal of Histochemistry and Cytochemistry , 50 pp. 113-115.

Brown, RSD; Dogan, A; Ell, PJ; Payne, HA; Masters, JRW; Harland, SJ; (2002) The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer. PROSTATE CANCER P D , 5 (2) 144 - 151. 10.1038/sj.pcan.4500581.

Brown, RSD; Edwards, J; Dogan, A; Payne, H; Harland, SJ; Bartlett, JMS; Masters, JRW; (2002) Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer. J PATHOL , 198 (2) 237 - 244. 10.1002/path.1206.

Budhram-Mahadeo, V; Morris, P; Ndisang, D; Irshad, S; Lozano, G; Pedley, B; Latchman, DS; (2002) The Brn-3a POU family transcription factor stimulates p53 gene expression in human and mouse tumour cells. NEUROSCI LETT , 334 (1) 1 - 4.

Bunn, PA; Calvert, H; (2002) Pemetrexed, a novel multitargeted antifolate: Current development and future directions - Introduction. SEMIN ONCOL , 29 (2) 1 - 2. 10.1053/sonc.2002.30757.

Burcombe, RJ; Makris, A; Pittam, M; Lowe, J; Emmott, J; Wong, WL; (2002) Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [F-18]- fluorodeoxyglucose positron emission tomography. European Journal of Cancer , 38 (3) pp. 375-379.

Burcombe, RJ; Makris, A; Wilson, GD; (2002) Evaluation of topoisomerase II-alpha as a predictor of clinical and pathological response to neoadjuvant chemotherapy in operable breast cancer. In: (pp. 447a-).

Burger, AM; Fiebig, HH; Hagan, DR; Tiberghien, A; Howard, PW; Schultz, R; Hartley, JA; (2002) The monomer pyrrolobenzodiazepine (PBD) DNA minor-groove binding agent DRH-417 (NSC 709119) shows pre-clinical activity in human renal cell carcinoma. In: (pp. 5719-).

Burk, K; (2002) Thirst for Knowledge. Prospect (8/2002) pp. 40-43.

C

Calvert, AH; Egorin, MJ; (2002) Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies. EUR J CANCER , 38 (1) 11 - 16.

Calvert, H; (2002) Folate status and the safety profile of antifolates. SEMINARS IN ONCOLOGY , 29 (2) 3 - 7. 10.1053/sonc.2002.30761.

Calvert, H; Bunn, PA; (2002) Future directions in the development of pemetrexed. SEMINARS IN ONCOLOGY , 29 (2) 54 - 61. 10.1053/sonc.2002.30761.

Calvert, H; Jodrell, DI; Cassidy, J; Harris, AL; (2002) Efficacy, safety, and cost of new anticancer drugs - Pessimistic conclusion was not justified. BRIT MED J , 325 (7375) 1302 - 1303.

Carr, WH; Little, AM; Mocarski, E; Parham, P; (2002) NK-cell mediated lysis of autologous HCMV infected skin fibroblasts is highly variable among NK cell cloes and polyclonal NK-cell lines. Clinical Immunology , 105 pp. 126-140.

Casey, JL; Napier, MP; King, DJ; Pedley, RB; Chaplin, LC; Weir, N; Skelton, L; (2002) Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study. Br J Cancer , 86 (9) pp. 1401-1410. 10.1038/sj.bjc.6600198.

Casey, JL; Napier, MP; King, DJ; Pedley, RB; Chaplin, LC; Weir, N; Skelton, L; (2002) Tumour targeting of humanised cross-linked divalent-fab ' antibody fragments: a clinical phase I/II study. BRIT J CANCER , 86 (9) 1401 - 1410. 10.1038/sj/bjc/6600198.

Chakrabarti, S; Avivi, I; Mackinnon, S; Ward, K; Kottaridis, PD; Osman, H; Waldmann, H; (2002) Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. BRIT J HAEMATOL , 119 (4) 1125 - 1132.

Chakrabarti, S; Mackinnon, S; Chopra, R; Kottaridis, PD; Peggs, K; O'Gorman, P; Chakraverty, R; (2002) High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. BLOOD , 99 (12) 4357 - 4363.

Chakraverty, R; Peggs, K; Chopra, R; Milligan, DW; Kottaridis, PD; Verfuerth, S; Geary, J; (2002) Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. BLOOD , 99 (3) 1071 - 1078.

Chantret, I; Dupré, T; Delenda, C; Bucher, S; Dancourt, J; Barnier, A; Charollais, A; (2002) Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferase. J Biol Chem , 277 (28) pp. 25815-25822. 10.1074/jbc.M203285200. Gold open access

Chatterjee, R; KOTTARIDIS, PD; McGarrigle, HH; Linch, DC; (2002) Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. Bone Marrow Transplantation (607) 610-.

Chatterjee, R; Kottaridis, PD; McGarrigle, HH; Linch, DC; (2002) Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. Bone Marrow Transplant , 29 (7) pp. 607-610. 10.1038/sj.bmt.1703421.

Chatterjee, R; Kottaridis, PD; McGarrigle, HH; Linch, DC; (2002) Post-transplant complications - Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. BONE MARROW TRANSPL , 29 (7) 607 - 610. 10.1038/sj/bmt/1703421.

Chen, FE; Aubert, G; Travers, P; Dodi, IA; Madrigal, JA; (2002) HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy. Cytotherapy , 4 (1) pp. 41-48.

Chen, FE; Aubert, G; Travers, P; Dodi, IA; Madrigal, JA; (2002) HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy. Cytotherapy , 4 (1) pp. 41-48.

Chow, E; Coia, L; Wu, J; Nanjan, N; Kirkbride, P; Hoskin, PJ; (2002) Debate: this house believes that multiple-fraction radiotherapy is a barrier to referral for palliative radiotherapy for bone metastases. Current Oncology , 9 pp. 60-66.

Chow, E; Wu, JSY; Hoskin, P; Coia, LR; Bentzen, SM; Blitzer, PH; (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiotherapy And Oncology , 64 (3) pp. 275-280.

Chow, E; Wu, JSY; Hoskin, P; Coia, LR; Bentzen, SM; Blitzer, PH; (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. International Journal of Cancer p. 7.

Clark, FJ; Chakraverty, R; (2002) Role of dendritic cells in graft-versus-host disease. J HEMATOTH STEM CELL , 11 (4) 601 - 616.

Cohen, H; (2002) Where do we go from here? [Lecture]. Presented at: SHOT annual symposium, London.

Cohen, H; Love, E; Todd, A; Soldan, K; Jones, H; Williamson, LM; (2002) 5 years of serious hazards of transfusion (SHOT): powerful data, slow progress in implementing recommendations. In: (Proceedings) British society for haematology annual scientific meeting.

Colledge, L; Bennett, CL; Reay, PA; Blackburn, CC; (2002) Rapid constitutive generation of a specific peptide-MHC class II complex from intact exogenous protein in immature murine dendritic cells. EUROPEAN JOURNAL OF IMMUNOLOGY , 32 (11) pp. 3246-3255. 10.1002/1521-4141(200211)32:11<3246::AID-IMMU3246>3.0.CO;2-B.

Colombari, R; Togni, R; Furlanetto, A; Quaglia, A; Dhillon, A; Demichelis, F; Spinoso, A; (2002) Royal free (RFH) scoring system for unifocal hepatocellular carcinoma (HCC) < 5 cm diameter: A valuable prognostic tool. J HEPATOL , 36 78 - 78.

Colombo, E; Marine, JC; Danovi, D; Falini, B; Pelicci, PG; (2002) Nucleophosmin regulates the stability and transcriptional activity of p53. NAT CELL BIOL , 4 (7) 529 - 533. 10.1038/ncb814.

Conde, L; Mateos, A; Herrero, J; Dopazo, J; (2002) Unsupervised reduction of the dimensionality followed by supervised learning with a perceptron improves the classification of conditions in DNA microarray gene expression data. In: Bourlard, H and Adali, T and Bengio, S and Larsen, J and Douglas, S, (eds.) (Proceedings) 12th IEEE Workshop on Neural Networks for Signal Processing. (pp. pp. 77-86). IEEE

Cooke, SP; Pedley, RB; Boden, R; Begent, RHJ; Chester, KA; (2002) In vivo tumor delivery of a recombinant single chain Fv::tumor necrosis factor-alpha fusion [correction of factor: a fusion] protein. Bioconjug Chem , 13 (1) pp. 7-15.

Cooke, SP; Pedley, RB; Boden, R; Begent, RHJ; Chester, KA; (2002) In vivo tumor delivery of a recombinant single chain fv :: tumor necrosis factor-alpha fusion protein (vol 13, pg 7, 2002). BIOCONJUGATE CHEM , 13 (2) 385 - 385. 10.1021/bc020015h.

Cooke, SP; Pedley, RB; Boden, R; Begent, RHJ; Chester, KA; (2002) In vivo tumor delivery of a recombinant single-chain Fv::Tumor necrosis factor: A fusion protein. Bioconjugate Chemistry , 13 (1) pp. 7-15. 10.1021/bc000178a.

Cooke, SP; Pedley, RB; Boden, R; Begent, RHJ; Chester, KA; (2002) In vivo tumor delivery of a recombinant single-chain Fv::Tumor necrosis factor: A fusion protein. BIOCONJUGATE CHEM , 13 (1) 7 - 15. 10.1021/bc000178a.

Corell, A; Cox, ST; Soteriou, B; Ramon, D; Madrigal, JA; Marsh, SGE; (2002) Complete cDNA sequences of the HLA-DRB1*14011,*1402,*1403 and*1404 alleles. TISSUE ANTIGENS , 59 (1) pp. 66-69. 10.1034/j.1399-0039.2002.590116.x.

Corell, A; Little, AM; Marsh, SGE; Madrigal, JA; (2002) HLA matching in unrelated stem cell transplantation: what to type for? Inmunologia , 21: pp. 169-177.

Corrie, P; Mayer, A; Shaw, J; D'Ath, S; Blagden, S; Blesing, C; Price, P; (2002) Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients. BRITISH JOURNAL OF CANCER , 87 (7) pp. 716-719. 10.1038/sj.bjc.6600523.

Cox, ST; Ogilvie, H; Bohan, EM; Holman, R; Prentice, HG; Potter, M; Madrigal, JA; (2002) Sequence of two new HLA-Cw alleles: HLA-Cw*0313 and HLA-Cw*1208. Tissue Antigens , 59 (1) pp. 49-51.

Cox, ST; Ogilvie, H; Bohan, EM; Holman, R; Prentice, HG; Potter, M; Madrigal, JA; (2002) Sequence of two new HLA-Cw alleles: HLA-Cw*0313 and HLA-Cw*1208. Tissue Antigens , 59 (1) pp. 49-51.

Craddock, C; Hochhauser, D; (2002) Realising the potential of targeted therapies in oncology. LANCET , 360 (9331) 424 - 425.

Craig, CE; Gallen, IWPFROIWPO; (2002) Possible functional regression of insulinoma with prolonged octreotide. Possible functional regression of insulinoma with prolonged octreotide.

Crawley, C; Lalanacette, M; Szydlo, R; Gilleece, M; Juliusson, G; Michallet, M; Mackinnon, S; (2002) Reduced intensity conditioned allografts for myeloma: A study from the Chronic Leukaemia Working Party of the EBMT. In: BLOOD. (pp. 144A - 144A). AMER SOC HEMATOLOGY

D

Davidoff, AM; Nathwani, AC; Spurbeck, WW; Ng, CYC; Zhou, J; Vanin, EF; (2002) rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice. Cancer Res , 62 (11) pp. 3077-3083.

Davies, H; Bignell, GR; Cox, C; Stephens, P; Edkins, S; Clegg, S; Teague, J; (2002) Mutations of the BRAF gene in human cancer. Nature , 417 (6892) pp. 949-954. 10.1038/nature00766.

Davies, JK; Koh, MB; Prentice, HG; Lowdell, MW; (2002) Selective allodepletion by immunomagnetic sorting can reduce alloreactivity in vitro, can be done at a clinical scale and preserves in vitro activity against CMV and EBV. BONE MARROW TRANSPL , 29 S45 - S46.

Davis, BA; Porter, JB; (2002) Results of long term iron chelation treatment with deferoxamine. ADV EXP MED BIOL , 509 91 - 125.

De Silva, IU; McHugh, PJ; Clingen, PH; Hartley, JA; (2002) Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin. NUCLEIC ACIDS RES , 30 (17) 3848 - 3856. Gold open access

Delenda, C; Audit, M; Danos, O; (2002) Biosafety issues in lentivector production. Curr Top Microbiol Immunol , 261 pp. 123-141.

Diatloff-Zito, C; Marquis, E; Nicole, A; Labit, H; Junien, C; Robert, JJ; (2002) Altered DNA methylation pattern in the transient neonatal diabetes determined by the genomic sequencing method. In: AMERICAN JOURNAL OF HUMAN GENETICS. (pp. 175 - 175). UNIV CHICAGO PRESS

Diss, TC; Liu, HX; Du, MQ; Isaacson, PG; (2002) Improvements to B-cell clonality analysis using PCR amplification of immunoglobin light chain genes. Molecular Pathology , 55 (2) pp. 98-101.

Dodi, IA; Van Rhee, F; Forde, HC; Roura-Mir, C; Jaraquemada, D; Goldman, JM; Madrigal, JA; (2002) CD4(+) bias in T cells cloned from a CML patient with active graft versus leukemia effect. Cytotherapy , 4 (4) pp. 353-363.

Dodi, IA; Van Rhee, F; Forde, HC; Roura-Mir, C; Jaraquemada, D; Goldman, JM; Madrigal, JA; (2002) CD4(+) bias in T cells cloned from a CML patient with active graft versus leukemia effect. Cytotherapy , 4 (4) pp. 353-363.

Dogan, A; Isaacson, PG; (2002) Lymphomas in the gut: a practical approach. CPD Bulletin , 4 pp. 18-24.

Donohoe, S; Quenby, S; Mackie, I; Panal, G; Farquharson, R; Malia, R; Kingdom, J; (2002) Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies. LUPUS , 11 (1) 11 - 20. 10.1191/0961203302lu132oa.

Du, MQ; Diss, TC; Liu, HX; Ye, HT; Hamoudi, RA; Cabecadas, J; Dong, HY; (2002) KSHV- and EBV-associated germinotropic lymphoproliferative disorder. BLOOD , 100 (9) pp. 3415-3418. 10.1182/blood-2002-02-0487. Green open access
file

Du, MQ; Isaacson, PG; (2002) Gastric MALT lymphoma: from aetiology to treatment. The Lancet Oncology , 3 pp. 97-104.

Duarte, R.F.; Chen, F.E.; Lowdell, M.W.; Potter, M.N.; Lamana, M.L.; Prentice, H.G.; Madrigal, J.A.; (2002) Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy. Gene Therapy , 9 (20) pp. 1359-1368. 10.1038/sj.gt.3301807.

Duarte, RF; Chen, FE; Lowdell, M; Lamana, ML; Potter, M; Bueren, JA; Prentice, HG; (2002) Mechanisms of functional impairment of T lymphocytes following polyclonal expansion for retrovirally mediated gene transfer. TISSUE ANTIGENS , 59 p. 66.

Duarte, RF; Chen, FE; Lowdell, MW; Potter, MN; Lamana, ML; Prentice, HG; Madrigal, JA; (2002) Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: Implications for gene therapy. Gene Therapy , 9 (20) pp. 1359-1368. 10.1038/sj.gt.3301807.

Duarte, RF; Chen, FE; Lowdell, MW; Potter, MN; Lamana, ML; Prentice, HG; Madrigal, JA; (2002) Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy. GENE THER , 9 (20) 1359 - 1368. 10.1038/sj.gt.3301807.

Dunn, PPJ; Cox, ST; Little, AM; (2002) Sequencing protocols for detectio of HLA class I polymorphism. In: Powis, SH and Vaughan, RW, (eds.) Methods in Molecular Biology. (pp. 191-222). Humana Press Inc: Totowa.

Dunne, C; Little, AM; Cox, ST; Masson, D; Crowley, J; Barnes, T; Marsh, SGE; (2002) Identification and nucleotide sequence of a new null allele, HLA B*3540N. TISSUE ANTIGENS , 59 (6) pp. 522-524. 10.1034/j.1399-0039.2002.590610.x.

Dunne, C; Little, AM; Cox, ST; Masson, D; Crowley, J; Barnes, T; Marsh, SGE; (2002) Identification and nucleotide sequence of a new null allele, HLA B*3540N. Tissue Antigens , 59 (6) pp. 522-524.

E

El Emir, E; Petrie, IA; Boxer, GM; Boden, R; Dearling, JLJ; Raleigh, JA; Mantavani, A; (2002) Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice. British Journal of Cancer , 86 S112-S112.

El-Emir, E; Petrie, ; I, A; Boxer, ; G, M; Boden, ; R, ; (2002) Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 257-).

El-Emir, E; Petrie, IA; Boxer, GM; Boden, R; Dearling, JLJ; Raleigh, JA; Mantavani, A; (2002) Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice. BRIT J CANCER , 86 S112 - S112.

Ellis, PE; Fong, LFWT; Rolfe, KJ; Crow, JC; Reid, WMN; Davidson, T; MacLean, AB; (2002) The role of p53 and Ki67 in Paget's disease of the vulva and the breast. GYNECOL ONCOL , 86 (2) 150 - 156. 10.1006/gyno.2002.6629.

Ellis, PE; Fong, LFWT; Rolfe, KJ; Crow, JC; Reid, WMN; Davidson, T; MacLean, AB; (2002) The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast. ANTICANCER RESEARCH , 22 (2A) 857 - 861.

Enver, T; Brown, J; Bruno, L; Gale, K; Gupta, R; Heyworth, C; Hoffmann, R; (2002) Transcriptional programming in haematopoietic stem cells. EXPERIMENTAL HEMATOLOGY , 30 (6) p. 37.

Enver, T; Brown, J; Bruno, L; Gupta, R; Heyworth, C; Hoffmann, R; Joshi, C; (2002) Dynamic analysis of stem cell self renewal and differentiation using global gene expression profiling. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 721A-721A). AMER SOC HEMATOLOGY

Ezoe, S; Matsumura, I; Nakata, S; Gale, K; Ishihara, K; Minegishi, N; Machii, T; (2002) GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins. BLOOD , 100 (10) pp. 3512-3520. 10.1182/blood-2002-04-1177.

Ezoe, S; Matsumura, I; Shibayama, H; Satoh, Y; Enver, T; Kanakura, Y; (2002) GATA-1 and GATA-2 inhibit cytokine-dependent growth of hematopoietic cells through the inhibition of MAPK activities. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 522A-523A). AMER SOC HEMATOLOGY

F

Ferns, RB; Fletcher, H; Bradley, S; Mackinnon, S; Hunt, C; Tedder, RS; (2002) The prospective evaluation of a nested polymerase chain reaction assay for the early detection of Aspergillus infection in patients with leukaemia or undergoing allograft treatment. BRIT J HAEMATOL , 119 (3) 720 - 725.

Fielding, A; (2002) Cancer vaccines: unanswered questions. May 16, 2002, Phacilitate Spring Vaccine Forum, Cancer Vaccines, Paris, France. Expert Rev Vaccines , 1 (2) pp. 131-133. 10.1586/14760584.1.2.131.

Fielding, A; Bucheit, A; Kumar, S; Yu, L; von Messling, V; (2002) Replicating attenuated measles virus can be engineered to enter cells through the CD20 antigen. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 201A-202A). AMER SOC HEMATOLOGY

Fielding, A; Grote, D; Cattaneo, R; (2002) The anti-lymphoma efficacy of replicating, attenuated measles virus is enhanced by viral expression of GM-CSF. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 578A-578A). AMER SOC HEMATOLOGY

Firat, H; Cochet, M; Rohrlich, P-S; Garcia-Pons, F; Darche, S; Danos, O; Lemonnier, FA; (2002) Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice. Int Immunol , 14 (8) pp. 925-934.

Firat, H; Zennou, V; Garcia-Pons, F; Ginhoux, F; Cochet, M; Danos, O; Lemonnier, FA; (2002) Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy. J Gene Med , 4 (1) pp. 38-45.

Flanagan, AM; Massey, HM; Wilson, C; Vellodi, A; Horton, MA; Steward, CG; (2002) Macrophage colony-stimulating factor and rand ligand NF-kB. Bone , 30 pp. 85-90.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Dearling, J; Watson, R; Boden, R; (2002) A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection. Cancer , 94 (4 SUPPL.) pp. 1249-1257.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Dearling, J; Watson, R; Boden, R; (2002) A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection. In: CANCER. (pp. 1249 - 1257). JOHN WILEY & SONS INC

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Dearling, J; Watson, R; Boden, R; (2002) A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection. Cancer , 94 (4 Suppl) pp. 1249-1257.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Bhatia, J; Morris, R; (2002) Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour. International Journal of Radiation Biology , 78 (5) pp. 407-415. 10.1080/09553000110117818.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Bhatia, J; Morris, R; (2002) Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour. INT J RADIAT BIOL , 78 (5) 407 - 415. 10.1080/09553000110117818.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Dearling, J; Boden, RABRHJ; (2002) Antibody and radionuclide characteristics can enhance the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour. International Journal of Radiation Biology , 78 pp. 407-415.

Forbes, LV; Gale, RE; Pizzey, A; Pouwels, K; Nathwani, A; Linch, DC; (2002) An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia. ONCOGENE , 21 (39) 5981 - 5989. 10.1038/sj.onc.1205767.

Ford, HER; Mitchell, F; Cunningham, D; Farrugia, DC; Hill, ME; Rees, C; Calvert, AH; (2002) Patterns of elevation of plasma 2 '-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331. CLIN CANCER RES , 8 (1) 103 - 109.

Fordham-Skelton, AP; Chilley, P; Lumbreras, V; Reignoux, S; Fenton, TR; Dahm, CC; Pages, M; (2002) A novel higher plant protein tyrosine phosphatase interacts with SNF1-related protein kinases via a KIS (kinase interaction sequence) domain. Plant J , 29 (6) pp. 705-715.

Foroni, L; Hoffbrand, AV; (2002) Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemia. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY , 15 (1) pp. 71-90. 10.1053/beha.2002.0186.

Foroni, L; Mortuza, YF; Hoffbrand, AV; (2002) Molecular investigation of minimal residual disease in adult acute lymphoblastic leukemia of B lineage. In: Zipf, TF and Johnson, DA, (eds.) Leukemia and Lymphoma: detection of minimal residual disease. (pp. 97-118). Human Press Inc: Totowa.

Francis, RJ; Green, AJ; Baig, S; Knell, V; Frisken, I; Bowen, RL; Hilson, AJW; (2002) A novel approach to assessing response to chemotherapy using hybrid camera FDG PET. British Journal of Cancer , 86 S100-S100.

Francis, RJ; Green, AJ; Baig, S; Knell, V; Frisken, I; Bowen, RL; Hilson, AJW; (2002) A novel approach to assessing response to chemotherapy using hybrid camera FDG PET. BRIT J CANCER , 86 S100 - S100.

Francis, RJ; Sharma, SK; Springer, C; Green, AJ; Hope-Stone, LD; Sena, L; Martin, J; (2002) A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. British Journal of Cancer , 87 (6) pp. 600-607. 10.1038/sj.bjc.6600517.

Francis, RJ; Sharma, SK; Springer, C; Green, AJ; Hope-Stone, LD; Sena, L; Martin, J; (2002) A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. BRIT J CANCER , 87 (6) 600 - 607. 10.1038/sj.bjc.6600517.

Freeman, A; Treurnicht, K; Munson, P; Miller, K; Parkinson, MC; (2002) A comparison of basal cell markers used in the prostate. HISTOPATHOLOGY , 40 (5) pp. 492-494. 10.1046/j.1365-2559.2002.t01-6-01390.x.

G

GUPTA, R; Bain, BJ; (2002) Cytogenetic and molecular genetic abnormalities in systemic mastocytosis. Acta Haematol , 107 (2) pp. 123-128. 10.1159/000046642.

GUPTA, R; Knight, CL; Bain, BJ; (2002) Receptor tyrosine kinase mutations in myeloid neoplasms. British Journal of Haematology , 117 (3) pp. 489-508.

Gale, RE; (2002) Basic sciences of the myeloproliferative diseases: Pathogenic mechanisms of ET and PV. INT J HEMATOL , 76 305 - 310.

Gameiro, P; Moreira, I; Yetgin, S; Papaioannou, M; Potter, MN; Prentice, HG; Hoffbrand, AV; (2002) Polymerase chain reaction (PCR)- and reverse transcription PCR-based minimal residual disease detection in long-term follow-up of childhood acute lymphoblastic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 119 (3) pp. 685-696. 10.1046/j.1365-2141.2002.03911.x.

Gameiro, P; Mortuza, FY; Hoffbrand, AV; Foroni, L; (2002) Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor gamma and delta gene rearrangements. HAEMATOLOGICA , 87 (11) pp. 1126-1134. Gold open access

Ganeshaguru, K; Wickremasinghe, RG; Jones, DT; Gordon, M; Hart, SM; Virchis, AE; Prentice, HG; (2002) Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica , 87 (2) pp. 167-176. Gold open access

Ganeshaguru, K; Wickremasinghe, RG; Jones, DT; Gordon, M; Hart, SM; Virchis, AE; Prentice, HG; (2002) Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. HAEMATOLOGICA , 87 (2) 167 - 176. Gold open access

Gardiner, C; Cooper, PC; Makris, M; Mackie, IJ; Malia, RG; Machin, SJ; (2002) An evaluation of screening tests for defects in the protein C pathway: commercial kits lack sensitivity and specificity. BLOOD COAGUL FIBRIN , 13 (2) 155 - 163.

Gardiner, C; Mackie, IJ; Furrs, SA; Piegsa, K; Guillebaud, J; Machin, SJ; (2002) Acquired resistance to activated protein C is more pronounced in women receiving combined oral contraceptives containing desogestrel than levonorgestrel and is associated with low protein S levels. In: BLOOD. (pp. 113B - 113B). AMER SOC HEMATOLOGY

Gasco, M; Sullivan, A; Repellin, C; Brooks, L; Farrell, PJ; Tidy, JA; Dunne, B; (2002) Coincident inactivation of 14-3-3σ and p16INK4a is an early event in vulval squamous neoplasia. Oncogene , 21 (12) pp. 1876-1881. 10.1038/sj.onc.1205256.

Geary, JE; Verfuerth, S; Thomas, AC; Peggs, KS; Mackinnon, S; (2002) Kinetics of lineage-specific chimerism following an alemtuzumab (Campath-1H) reduced intensity regimen and the effect on chimerism of donor leukocyte infusions. In: BLOOD. (pp. 398B - 399B). AMER SOC HEMATOLOGY

Gentry, CC; Okolo, SO; Fong, LFWT; Crow, JC; MacLean, AB; Perrett, CW; (2002) Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium. Clinical Science , 101 (6) pp. 691-695.

Gerrard, G; Ganeshaguru, K; Baker, R; Potter, M; Prentice, HG; Burgess, M; Herbert, L; (2002) Inhibition of P-gp activity in AML patients treated with zosuquidar trihydrochloride (LY335979): In vitro data from a phase 1 trial. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 67A-67A). AMER SOC HEMATOLOGY

Gerrard, G; Ganeshaguru, K; Baker, R; Potter, M; Prentice, HG; Burgess, M; Herbert, L; (2002) Inhibition of P-gp activity in aml patients treated with zosuquidar trihydrochloride (LY335979): in vitro data from a phase 1 trial. BLOOD , 100 67a-.

Gibson, IR; Hing, KA; Revell, PA; Santos, JD; Best, SM; Bonfield, W; (2002) Enhanced in vivo response to silicate-substituted hydroxyapatite. UNSPECIFIED, London.

Gill, J; Bourboulia, D; Wilkinson, J; Hayes, P; Cope, A; Marcelin, A-G; Calvez, V; (2002) Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma. J Acquir Immune Defic Syndr , 31 (4) pp. 384-390.

Gill, J; Bourboulia, D; Wilkinson, J; Hayes, P; Cope, A; Marcelin, AG; Calvez, V; (2002) Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma-associated herpesvirus infection in patients with and without Kaposi sarcoma. JAIDS-J ACQ IMM DEF , 31 (4) 384 - 390.

Goetz, P; Lafuente, J; Revesz, T; Galloway, M; Dogan, A; Kitchen, N; (2002) Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue of the dura mimicking the presentation of an acute subdural hematoma - Case report and review of the literature. J NEUROSURG , 96 (3) 611 - 614.

Going, JJ; Keith, WN; Neilson, L; Stoeber, K; Stuart, RC; Williams, GH; (2002) Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa. GUT , 50 (3) 373 - 377. Green open access
file

Gonzalez, M; Quezada, SA; Blazar, BR; Panoskaltsis-Mortari, A; Rudensky, AY; Noelle, RJ; (2002) The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning. J IMMUNOL , 169 (10) 5581 - 5589.

Gordon, FH; Hamilton, MI; Donoghue, S; Greenlees, C; Palmer, T; Rowley-Jones, D; Dhillon, AP; (2002) A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin. ALIMENT PHARM THER , 16 (4) 699 - 705.

Gore, M; Oza, A; Rustin, G; Malfetano, J; Calvert, H; Clarke-Pearson, D; Carmichael, J; (2002) A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer. EUR J CANCER , 38 (1) 57 - 63.

Gower, NH; Rudd, RM; James, LE; Gregory, W; Eisen, T; Lee, SM; Harper, PG; (2002) Gemcitabine and carboplatin (GC) versus mitomycin, ifosfamide and cisplatin (MIP): a phase III randomised comparison in stage IIIb or IV non-small cell lung cancer (NSCLC). In: (pp. 399-).

Gower, NH; Rudd, RM; James, LE; Gregory, W; Eisen, T; Lee, SM; Harper, PG; (2002) Gemcitabine/carboplatin (GC) versus mitomycin/ifosfamide/cisplatin (MIP): A randomised comparison in patients with advanced non-small cell lung cancer (NSCLC). BRITISH JOURNAL OF CANCER , 86 S1-S1.

Grasso, A; Quaglia, A; Montalto, P; Dhillon, AP; Patch, D; Davidson, B; Rolles, K; (2002) HCC and liver transplantation (LT): Risk factors for recurrence. In: J HEPATOL. (pp. 80 - 80). ELSEVIER SCIENCE BV

Grimaldi, KA; McGurk, CJ; McHugh, PJ; Hartley, JA; (2002) PCR-based methods for detecting DNA damage and its repair at the sub-gene and single nucleotide levels in cells. MOL BIOTECHNOL , 20 (2) 181 - 196.

Grimwade, D; Outram, SV; Flora, R; Ings, SJ; Pizzey, AR; Morilla, R; Craddock, CF; (2002) The T-Lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells. CANCER RES , 62 (16) 4730 - 4735.

Gupta, N; Saleem, A; Osman, S; Hoskin, P; Price, PM; Aboagye, EO; (2002) Carbogen and nicotinamide selectively increase chemotherapy delivery and blood flow to liver metastasis. British Journal of Cancer , 86 S14-S14.

H

Hackshaw, AK; Wald, NJ; (2002) Estimation of risk in second trimester serum screening for Down syndrome among women who have already had first trimester screening. Prenatal Diagnosis , 22 pp. 1051-1055.

Hale, G; Slavin, S; Goldman, JM; Mackinnon, S; Giralt, S; Waldmann, H; (2002) Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nomnyeloablative conditioning? BONE MARROW TRANSPL , 30 (12) 797 - 804. 10.1038/sj.bmt.1703733.

Hamidi, AEL; Liu, HX; Zhang, Y; Hamoudi, R; Kocjan, G; Du, MQ; (2002) Archival cervical smears: a versatile resource for molecular investigations. CYTOPATHOLOGY , 13 (5) 291 - 299.

Hamoudi, RA; Diss, TC; Oksenhendler, E; Pan, LX; Carbone, A; Boshoff, C; Isaacson, P; (2002) Different cellular origin between primary effusion lymphoma with and without EBV infection. In: BLOOD. (pp. 564A - 564A). AMER SOC HEMATOLOGY

Hanawa, H; Kelly, PF; Nathwani, AC; Persons, DA; Vandergriff, JA; Hargrove, P; Vanin, EF; (2002) Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Molecular Therapy , 5 (3) pp. 242-251.

Haralambieva, E; Jones, M; Roncador, GM; Cerroni, L; Lamant, L; Ott, G; Rosenwald, A; (2002) Tyrosine phosphorylation in human lymphomas. Histochem J , 34 (11-12) pp. 545-552.

Harbord, M; Novelli, M; Canas, B; Power, D; Davis, C; Godovac-Zimmermann, J; Roes, J; (2002) Ym1 is a neutrophil granule protein that crystallizes in p47(phox)-deficient mice. J BIOL CHEM , 277 (7) 5468 - 5475. 10.1074/jbc.M110635200. Gold open access

Harney, J; Goodchild, K; Glynne-Jones, R; Phillips, H; Hoskin, PJ; Saunders, MI; (2002) A Phase I/II Study of CHARTWEL with concurrent chemotherapy in locally advanced inoperable carcinoma of the oesphagus. In: (pp. S27-).

Harney, J; Goodchild, K; Glynne-Jones, R; Phillips, H; Hoskin, PJ; Saunders, MI; (2002) A phase II study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of the oesophagus. In: (pp. 83-).

Harney, J; Shah, N; Joiner, M; Short, S; Saunders, MI; (2002) Low dose hyper-sensitivity- does it occur in normal skin? In:

Harney, J; Shah, N; Short, SC; Joiner, M; Saunders, MI; (2002) Low dose hyper-radiosensitivity - does it exist in normal skin? In: (pp. S57-).

Harney, J; Short, SC; Saunders, MI; (2002) Low dose hyper-radiosensitivity - A clinical assessment. In: (pp. S56-).

Harris, RA; Yang, A; Stein, RC; Lucy, K; Brusten, L; Herath, A; Parekh, R; (2002) Cluster analysis of an extensive human breast cancer cell line protein expression map database. PROTEOMICS , 2 (2) pp. 212-223. 10.1002/1615-9861(200202)2:2<212::AID-PROT212>3.0.CO;2-H.

Harrison, CJ; Foroni, L; (2002) Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Reviews in Clinical and Experimental Hematology , 6 (2) pp. 91-113.

Harrison, CJ; Mazzullo, H; Ross, FM; Cheung, KL; Gerrard, G; Harewood, L; Mehta, A; (2002) Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis. BRIT J HAEMATOL , 117 (2) 427 - 435.

Harrison, CN; Donohoe, S; Carr, P; Dave, M; Mackie, I; Machin, SJ; (2002) Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. THROMB HAEMOSTASIS , 87 (5) 802 - 807.

Harrison, P; Robinson, M; Liesner, R; Khair, K; Cohen, H; Mackie, I; Machin, S; (2002) The PFA-100((R)): a potential rapid screening tool for the assessment of platelet dysfunction. CLIN LAB HAEMATOL , 24 (4) 225 - 232.

Hart, SM; Foroni, L; (2002) Core binding factor genes and human leukemia. HAEMATOLOGICA , 87 (12) pp. 1307-1323. Gold open access

Hartley, JA; Spanswick, VJ; Pedley, RB; Hollingshead, MG; Alley, MC; Schultz, R; Gregson, SJ; (2002) In vitro antitumor activity and in vivo DNA interstrand crosslinking by the novel pyrrolobenzodiazepine dimer SJG-136 (NSC 694501). In: (pp. 2432-).

Hartley, JA; Spanswick, VJ; Pedley, RB; Hollingshead, MG; Alley, MC; Schultz, R; Gregson, SJ; (2002) In vitro activity and in vivo DNA interstrand crosslinking by the novel pyrrolobenzodiazepine dimer SJG-136 (NSC 694501). In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 489-).

Heelan, BT; Tormey, V; Amlot, PL; Payne, E; Mehta, A; Webster, AD; (2002) Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome. British Journal of Haematology , 118 (4) pp. 1078-1081.

Hercus, B; Saeed, S; Revell, PA; (2002) Expression profile of T cell associated molecules in the interfacial tissue of aseptically loosened prosthetic joints. J Mater Sci Mater Med , 13 (12) pp. 1153-1156.

Herrero, J; Dopazo, J; (2002) Combining hierarchical clustering and self-organizing maps for exploratory analysis of gene expression patterns. JOURNAL OF PROTEOME RESEARCH , 1 (5) pp. 467-470. 10.1021/pr025521v.

Herrero-Martinez, E; Sabin, CA; Evans, JG; Griffioen, A; Lee, CA; Emery, VC; (2002) The prognostic value of a single hepatitis C virus RNA load measurement taken early after human immunodeficiency virus seroconversion. J INFECT DIS , 186 (4) 470 - 476.

Heyworth, C; Pearson, S; May, G; Enver, T; (2002) Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells. EMBO JOURNAL , 21 (14) pp. 3770-3781. 10.1093/emboj/cdf368.

Hoskin, P; (2002) Secondary malignancies after radiotherapy. The Lancet Oncology , 3 (9) pp. 577-578.

Hoskin, PJ; (2002) Conformal radiotherapy to the prostate: are bigger fields better? Clinical Oncology , 14 (4) pp. 296-297.

Hoskin, PJ; (2002) FDG PET in the management of lymphoma: a clinical perspective. European Journal of Nuclear Medicine and Molecular Imaging , 29 (4) pp. 449-451.

Hoskin, PJ; (2002) Tumour hypoxia and vascularity in lymphoma. In: (pp. 615-).

Hoskin, PJ; (2002) Radiotherapy in cancer pain management. In: Rice, ASC and Warfield, CA and Justins, D and Eccleston, C and Arnold, E, (eds.) Clinical Pain Management. (pp. 253-258). : London.

Hoskin, PJ; (2002) Radiotherapy in palliative care. In: Rice, ASC and Warfield, CA and Justins, D and Eccleston, C and Arnold, E, (eds.) Clinical Pain Management. (pp. 281-292). Arnold: London.

Hoskin, PJ; Bownes, P; Summers, A; (2002) The influence of applicator angle on dosimetry in vaginal vault brachytherapy. British Journal of Radiology , 75 (891) pp. 234-237.

Hoskin, PJ; Grover, A; Bhana, R; (2002) Optimal radiotherapy dose for metastatic spinal canal compression. British Journal of Cancer , 86 S20-S20.

Hoskin, PJ; Morgan, DAL; Robinson, M; (2002) Erythropoetin supplementation for radical radiotherapy in head and neck cancer: an interim analysis of a randomized phase III trial. In: (pp. 83-).

Hoskin, PJ; Smith, P; Linch, DC; (2002) Late morbidity and survival in early stage Hodgkin's disease treated with involved field or wide field radiotherapy alone. In: (pp. 215-).

Howard, J; Hoffbrand, AV; Prentice, HG; Mehta, A; (2002) Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura. BRITISH JOURNAL OF HAEMATOLOGY , 117 (3) pp. 712-715. 10.1046/j.1365-2141.2002.03430.x.

Howard, TT; Lingerfelt, BM; Purnell, BL; Scott, AE; Price, CA; Townes, HM; McNulty, L; (2002) Novel furano analogues of duocarmycin C1 and C2: Design, synthesis, and biological evaluation of seco-iso- cyclopropylfurano[2,3-e]indoline (seco-iso-CFI) and seco- cyclopropyltetrahydrofurano[2,3-f]quinoline (seco-CFQ) analogues. Bioorganic and Medicinal Chemistry , 10 (9) pp. 2941-2952.

Howard, TT; Lingerfelt, BM; Purnell, BL; Scott, AE; Price, CA; Townes, HM; McNulty, L; (2002) Novel furano analogues of duocarmycin C1 and C2: Design, synthesis, and biological evaluation of seco-iso-cyclopropylfurano[2,3-e]indoline (seco-iso-CFI) and seco-cyclopropyltetrahydrofurano[2,3-f]quinoline (seco-CFQ) analogues. BIOORGAN MED CHEM , 10 (9) 2941 - 2952.

Hsieh, JK; Yap, D; O'Connor, DJ; Fogal, V; Fallis, L; Chan, F; Zhong, S; (2002) Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage. Molecular and Cellular Biology , 22 (1) pp. 78-93.

Hughes, A; Calvert, P; Azzabi, A; Plummer, R; Johnson, R; Rusthoven, J; Griffin, M; (2002) Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma. J CLIN ONCOL , 20 (16) 3533 - 3544. 10.1200/JCO.2002.10.073.

Hughes, SE; (2002) Cardiac stem cells. The Journal of Pathology (197) pp. 468-478.

Hughes, SE; (2002) Heart muscle disease. Medicine (30) pp. 89-91.

Hughes, SE; (2002) Expression of the Fibrogrowth Factor (FgF and the Fibroblast Growth Factor Receptor (FGFR)Multigene Families in Normal and Atherosclerotic Human Arteries. In: Pedro, C, (ed.) Fibroblast Growth Factor in the Cardiovascular System. (pp. 117-131). I Holzapfel: Munich.

Hulten, M; Tankimanonova, M; Dhanjal, S; (2002) A telomere depletion assay for non-invasive prenatal diagnosis by FISH. In: JOURNAL OF MEDICAL GENETICS. (pp. S24 - S24). BRITISH MED JOURNAL PUBL GROUP

Hulten, MA; Dhanjal, S; (2002) A telomere depletion assay for non-invasive prenatal diagnosis. In: EUROPEAN JOURNAL OF HUMAN GENETICS. (pp. 61 - 61). NATURE PUBLISHING GROUP

Huntly, BJP; Bench, AJ; Delabesse, E; Reid, AG; Li, J; Scott, MA; Campbell, L; (2002) Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability. In: BLOOD. (pp. 4547 - 4553). AMER SOC HEMATOLOGY

I

Imrie, KR; Linch, DC; Czuczman, MS; (2002) Debate on the conservative and aggressive treatment options for the optimal management of indolent non-Hodgkin's lymphoma. ANTI-CANCER DRUGS , 13 S19 - S24.

International Collaborative Ovarian Neoplasm Group, ; (2002) Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. Lancet , 360 (9332) pp. 505-515. 10.1016/S0140-6736(02)09738-6.

J

James, CT; Ohazama, A; Tucker, AS; Sharpe, PT; (2002) Tooth development is independent of a Hox patterning programme. Dev Dyn , 225 (3) pp. 332-335. 10.1002/dvdy.10168.

James, LE; Rudd, RM; Gower, NH; Gregory, W; Lee, SM; Eisen, T; Ellis, P; (2002) A phase III randomised comparison of gemcitabine/carboplatin (GC) with cisplatin/etoposide (PE) in patients with poor prognosis small cell lung cancer (SCLC. In: (pp. 1170-).

James, LE; Rudd, RM; Gower, NH; Gregory, W; Lee, SM; Eisen, T; Ellis, P; (2002) A randomised phase III comparison of gemcitabine/carboplatin (GC) with cisplatin/etoposide (PE) in patients with poor prognosis small cell lung cancer (SCLC). In: (pp. 399-).

James, R.D.; Maughan, T.S.; Kerr, D.J.; Ledermann, J.A.; McArdle, C.; Seymour, M.T.; Cohen, D.; (2002) Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. The Lancet , 359 (9317) pp. 1555-1563. 10.1016/S0140-6736(02)08514-8.

Janinis, J; McTiernan, A; Driver, D; Mitchell, C; Cassoni, AM; Pringle, J; Kilby, A; (2002) A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma. ANN ONCOL , 13 (12) 1935 - 1944. 10.1093/annonc/mdf338.

Jarvis, M; Marzolini, MAV; Wang, X; Dickinson, A; (2002) Expression of heat shock protein 60 and 70 in a human in vitro skin explant model of acute graft versus host disease-Quantitative assessment using scanning laser confocal microscopy. In: (pp. S62-S62).

Jenner, RG; Boshoff, C; (2002) The molecular pathology of Kaposi's sarcoma-associated herpesvirus. BBA-REV CANCER , 1602 (1) 1 - 22.

Jennings, BH; (2002) Stopping Transcription in its Tracks. Nature Genetics , 32 pp. 87-88.

Jennings, I; Greaves, M; Mackie, IJ; Kitchen, S; Woods, TAL; Preston, FE; UK Natl External Quality Assessmen, ; (2002) Lupus anticoagulant testing: improvements in performance in a UKNEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. BRIT J HAEMATOL , 119 (2) 364 - 369.

Jones, B; Aird, E; Colyer, H; Dobbs, J; Harris, R; Hoskin, P; McKenzie, A; (2002) United Kingdom Radiation Oncology 1 conference (UKRO 1): Accuracy and uncertainty in radiotherapy. BRITISH JOURNAL OF RADIOLOGY , 75 (892) pp. 297-306.

Jones, DT; Ganeshaguru, K; Anderson, RJ; Jackson, TR; Bruckdorfer, KR; Low, SY; Palmqvist, L; (2002) Albumin activates the AKT signalling pathway and protects B-chronics lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood 10.1182/blood-2002-07-2143. Green open access
file

Joshi, CV; Enver, T; (2002) Plasticity revisited. CURRENT OPINION IN CELL BIOLOGY , 14 (6) pp. 749-755. 10.1016/A0955-0674(02)00392-7.

Judson, I; Leahy, M; Whelan, JS; Lorigan, P; Verrill, M; Grimer, R; Robinson, M; (2002) A guideline for the management of gastrointestinal stromal tumour (GIST). Sarcoma , 6 pp. 83-87. Gold open access

K

Kayyali, R; Hider, RC; Porter, JB; (2002) Combined chelation using deferiprone with deferoxamine induces synergistic inhibition of non-heme iron enzymes. In: BLOOD. (pp. 445A - 445A). AMER SOC HEMATOLOGY

Kenny, PA; Enver, T; Ashworth, A; (2002) Retroviral vectors for establishing tetracycline-regulated gene expression in an otherwise recalcitrant cell line. BMC MOL BIOL , 3 , Article 13. 10.1186/1471-2199-3-13. Green open access
file

Keshtgar, MRS; Lee, AC; Pickard, CDP; Briggs, GM; Falzon, M; Bigio, IJ; Bown, SG; (2002) Optical biopsy: The technique and experience in determining lymph node status in breast cancer. In: (Proceedings) Sentinel Node. : Yokohama, Japan.

Khan, AW; Dhillon, AP; Hutchins, R; Abraham, A; Shah, SR; Snooks, S; Davidson, BR; (2002) Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY , 28 (6) 637 - 644. 10.1053/ejso.2002.1307.

Kiakos, K; Howard, TT; Lee, M; Hartley, JA; McHugh, PJ; (2002) Saccharomyces cerevisiae RAD5 influences the excision repair of DNA minor groove adducts. J BIOL CHEM , 277 (46) 44576 - 44581. 10.1074/jbc.M208169200. Gold open access

Kichler, A; Chillon, M; Leborgne, C; Danos, O; Frisch, B; (2002) Intranasal gene delivery with a polyethylenimine-PEG conjugate. J Control Release , 81 (3) pp. 379-388.

Kirkby, N; Faraday, DBF; Short, S; C, W; M, J; M C, B; N, G; (2002) Mathematical modelling to develop a novel radiotherapy schedule for high grade brain tumours, based on phase distribution of low-dose hypersensitivity in human glioma cell lines. In:

Kirkham, LA; Bateman, AR; Melcher, AA; Vile, RG; Fielding, AK; (2002) Lack of specificity of cell-surface protease targeting of a cytotoxic hyperfusogenic gibbon ape leukaemia virus envelope glycoprotein. JOURNAL OF GENE MEDICINE , 4 (6) pp. 592-600. 10.1002/jgm.306.

Kitajima, K; Masuhara, M; Era, T; Enver, T; Nakano, T; (2002) GATA-2 and GATA-2/ER display opposing activities in the development and differentiation of blood progenitors. EMBO JOURNAL , 21 (12) pp. 3060-3069. 10.1093/emboj/cdf301.

Kiuru, M; Barker, K; Launonen, V; Lu, YJ; Bevan, S; Herva, R; Arola, J; (2002) Role of the HLRCC/MCUL1 locus in development of leiomyosarcomas and renal cell cancer. British Journal of Cancer , 87 pp. 446-448.

Koch, SSC; Thoresen, LH; Tikhe, JG; Maegley, KA; Almassy, RJ; Li, JK; Yu, XH; (2002) Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure. J MED CHEM , 45 (23) 4961 - 4974. 10.1021/jm02059n.

Kocjan, G; (2002) Cytopathology of the thyroid. Current Diagnostic Pathology , 8 pp. 201-205.

Kocjan, G; (2002) Pitfalls in cytology of endocrine organs. CPD Bulletin Cellular Pathology , 4 pp. 21-29.

Koh, MBC; Cotter, FE; Prentice, HG; Lowdell, MW; (2002) Removal of allo-specific lymphocytes from MHC-mismatched grafts prevents graft-versus-host disease in vivo and retains anti-viral CTL. LEUKEMIA , 16 (3) 411 - 411.

Koh, MBC; Prentice, HG; Corbo, M; Morgan, M; Cotter, FE; Lowdell, MW; (2002) Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment. BRIT J HAEMATOL , 118 (1) 108 - 116.

Kottaridis, PD; Craddock, C; Chopra, R; Milligan, DW; Vandenberghe, E; Parker, A; Hunter, A; (2002) Reduced intensity allogeneic transpalntation in patients above the age of 50 years. In: BLOOD. (pp. 454B - 454B). AMER SOC HEMATOLOGY

Kottaridis, PD; Gale, RE; Holt, M; Wheatley, K; Goldstone, AH; Burnett, AK; Linch, DC; (2002) Consolidation of AML therapy with autograft and allograft procedures does not negate the poor prognostic impact of FLT3 internal tandem duplications: Results from the UK MRC AML 10 and 12 trials. In: BLOOD. (pp. 75A - 75A). AMER SOC HEMATOLOGY

Kottaridis, PD; Gale, RE; Langabeer, SE; Frew, ME; Bowen, DT; Linch, DC; (2002) Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. BLOOD , 100 (7) 2393 - 2398. 10.1182/blood-2002-02-0420.

Kottaridis, PD; Peggs, K; Schmitz, N; Dreger, P; Boogaerts, MA; Ferrant, A; Demuynck, HM; (2002) Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: Further follow-up from the original randomised study to assess engraftment. LEUKEMIA LYMPHOMA , 43 (3) 531 - 536. 10.1080/10428190290012010.

Kottke, TJ; Blajeski, AL; Meng, XW; Svingen, PA; Ruchaud, S; Mesner, PW; Boerner, SA; (2002) Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells. pp. 804-815. Gold open access

Kralovicova, J; Marsh, SGE; Waller, MJ; Hammarstrom, L; Vorechovsky, I; (2002) The HLA-DRA*0102 allele: Correct nucleotide sequence and associated HLA haplotypes. TISSUE ANTIGENS , 60 (3) pp. 266-267. 10.1034/j.1399-0039.2002.600310.x.

Kularatne, BY; Lorigan, P; Browne, S; Suvarna, SK; Smith, NO; Lawry, J; (2002) Monitoring tumour cells in the peripheral blood of small cell lung cancer patients. CYTOMETRY , 50 (3) 160 - 167. 10.1002/cyto.10071.

Kumar, S; Chandra, J; Grote, D; Cattaneo, R; Kaufmann, S; Fielding, A; (2002) Bcl-2 over-expression results in decreased measles virus mediated cytotoxicity in lymphoma cell lines. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 577A-578A). AMER SOC HEMATOLOGY

Kyriacou, CA; Goldstone, AH; Taghipour, G; Avivi, I; Kottaridis, PD; Dogan, A; Linch, DC; (2002) Patients with chemosensitive angioimmunoblastic lymphoma (AITL) can be salvaged with autologous stem cell transplantation, irrespectively of the number of previous treatment lines. Analysis of 74 cases from the European Bone Marrow Transplant Registry (EBMT). In: BLOOD. (pp. 644A - 644A). AMER SOC HEMATOLOGY

L

Lagging, LM; Garcia, CE; Westin, J; Wejstal, R; Norkrans, G; Dhillon, AP; Lindh, M; (2002) Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. J CLIN MICROBIOL , 40 (11) 4224 - 4229. 10.1128/JCM.40.11.4224-4229.2002.

Lagging, LM; Westin, J; Svensson, E; Aires, N; Dhillon, AP; Lindh, M; Wejstal, R; (2002) Progression of fibrosis in untreated patients with hepatitis C virus infection. LIVER , 22 (2) 136 - 144.

Lakhani, SR; Flanagan, AM; (2002) Genetics, screening and management. In: Pathology of the breat and ovary in mutation carriers in familial breast and ovarian cancer. (pp. 108-124).

Lakhani, SR; Flanagan, AM; (2002) Pathology of the breast and ovary in mutation carriers in familial breast and ovarian cancer. In: Familial Breast and Ovarian Cancer: genetics, screening and management. (pp. 108-124). CUP: Cambridge.

Langabeer, SE; Gale, RE; Harvey, RC; Cook, RW; Mackinnon, S; Linch, DC; (2002) Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia. Leukemia , 16 (3) pp. 393-399. 10.1038/sj.leu.2402397.

Langabeer, SE; Gale, RE; Harvey, RC; Cook, RW; Mackinnon, S; Linch, DC; (2002) Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia. Leukemia , 16 (3) pp. 393-399. 10.1038/sj.leu.2402392.

Langabeer, SE; Gale, RE; Harvey, RC; Cook, RW; Mackinnon, S; Linch, DC; (2002) Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transript levels in patients with chronic myeloid leukaemia. LEUKEMIA , 16 (3) 393 - 399. 10.1038/sj/leu/2402392.

Langabeer, SE; Gale, RE; Rollinson, SJ; Morgan, GJ; Linch, DC; (2002) Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7. GENE CHROMOSOME CANC , 34 (1) 24 - 32. 10.1002/gcc.10031.

Langabeer, SE; Gale, RE; Rollinson, SJ; Morgan, GJ; Linch, DC; (2002) Mutations of the AMLI gene in acute myeloid leukemia of FAB types M0 and M7. Genes Chromosomes and Cancer , 34 (1) pp. 24-32. 10.1002/gcc.10031.

Ledermann, JA; Herd, R; (2002) High-Dose Chemotherapy in Ovarian Cancer in High Dose Chemotherapy:. In: Lorrigan, P and Vandenberghe, E, (eds.) Principles and Practice. (pp. 143-156). Martin Dunitz

Lee, AC; Keshtgar, MRS; Pickard, CDP; Kocjan, G; Falzon, M; Bigio, IJ; Ell, PJ; (2002) Comparative study of imprint cytology and elastic scattering spectroscopy in assessing sentinel lymph node status in breast cancer. In: (Proceedings) Sentinel Node. : Yokohama, Japan.

Lee, AC; Pickard, CDO; Briggs, GM; Bigio, IJ; Falzon, M; Keshtgar, MRS; Bown, SG; (2002) Elastic scattering spectroscopy for intraoperative detection of sentinel lymph node metastasis. In: (pp. 79-).

Lee, AC; Pickard, CDO; Keshtgar, MRS; Briggs, GM; Falzon, M; Lakhani, S; Bigio, I; (2002) Elastic scattering spectroscopy for the diagnosis of breast cancer. In: BRIT J SURG. (pp. 74 - 74). JOHN WILEY & SONS LTD

Lee, AC; Pickard, CDO; Keshtgar, MRS; Briggs, GM; Falzon, M; Lakhani, S; Ell, PJ; (2002) Intraoperative assessment by optical biopsy for lymph node metastasis in breast cancer. In: BRIT J SURG. (pp. 640 - 641). JOHN WILEY & SONS LTD

Lee, SM; James, LE; Mohamed-Ali, V; Boschoff, C; Snee, M; Brock, C; Leary, A; (2002) A phase II study of carboplatin/etoposide with thalidomide in small cell lung cancer (SCLC). In: (Proceedings) Oral presentation. 2002 ASCO Annual Meeting/38th Annual Meeting, Orlando, FL.. (pp. 1251-). Proceedings of the American Society of Clinical Oncology

Lee, Y.C.; Boehm, M.K.; Chester, K.A.; Begent, R.H.J.; Perkins, S.J.; (2002) Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy. Journal of Molecular Biology , 320 (1) pp. 107-127. 10.1016/S0022-2836(02)00403-5.

Lee, YC; Boehm, MK; Chester, KA; Begent, RHJ; Perkins, SJ; (2002) Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy. J MOL BIOL , 320 (1) 107 - 127. 10.1016/S0022-2836(02)00403-5.

Leonard, P; Ledermann, JA; (2002) Gastrointestinal Oncology in Practical Gastroenterology. In: Bloom, S, (ed.) Practical Gastroenterology. (pp. 225-240). Martin Dunitz

Leonard, P; Seymour, MT; James, R; Hochhauser, D; Ledermann, JA; (2002) Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancer. BRIT J CANCER , 87 (11) 1216 - 1220. 10.1038/sj.bjc.6606641.

Leonard, P; Seymour, MT; James, R; Hochhauser, D; Ledermann, JA; (2002) Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancer. Br J Cancer , 87 (11) pp. 1216-1220. 10.1038/sj.bjc.6600641.

Linch, DC; Yung, L; Smith, P; Maclennan, K; Jack, A; Hancock, B; Cunningham, D; (2002) A randomised trial of CHOP x 6-8 vs CHOP x 3+BEAM + ASCT in 457 patients with poor prognosis histologically aggressive non-Hodgkins lymphoma. BRIT J CANCER , 86 S1 - S2.

Liu, HX; Huang, XB; Zhang, Y; Ye, HT; El Hamidi, A; Kocjan, G; Dogan, A; (2002) Archival fixed histologic and cytologic specimens including stained and unstained materials are amenable to RT-PCR. DIAGN MOL PATHOL , 11 (4) 222 - 227.

Liu, HX; Ye, HT; Ruskone-Fourmestraux, A; De Jong, D; Pileri, S; Thiede, C; Lavergne, A; (2002) T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H-pylori eradication. GASTROENTEROLOGY , 122 (5) pp. 1286-1294. 10.1053/gast.2002.33047.

Liu, Y; Dodds, P; Emilion, G; Mungall, AJ; Dunham, I; Beck, S; Wells, RS; (2002) The human homologue of unc-93 maps to chromosome 6q27 - characterisation and analysis in sporadic epithelial ovarian cancer. BMC Genetics , 3 , Article 20. 10.1186/1471-2156-3-20. Green open access
file

Liu, Y; Emilion, G; Mungall, AJ; Dunham, I; Beck, S; Le Meuth-Metzinger, VG; Shelling, AN; (2002) Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer. ONCOGENE , 21 (3) 387 - 399.

Liu, ZD; Kayyali, R; Hider, RC; Porter, JB; Theobald, AE; (2002) Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: Structure-activity investigation of metalloenzyme inhibition by iron chelators. J MED CHEM , 45 (3) 631 - 639. 10.1021/jm010817i.

Lowdell, MW; Craston, R; Samuel, D; Wood, ME; O'Neill, E; Saha, V; Prentice, HG; (2002) Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells. BRIT J HAEMATOL , 117 (4) 821 - 827.

Lu, X; Kuwabara, P; Selwood, D; (2002) P53 Binding Polypeptide. WO/2004/031229.

M

MacGregor, A; Hackshaw, A; (2002) Prevention of migraine in the pill-free week of combined oral contraceptives using natural oestrogen supplements: A double-blind placebo controlled study. Journal of Family Planning and Reproductive Health Care , 28 (1) pp. 27-31.

Mackie, IJ; Lawrie, AS; Kitchen, S; Gaffney, PJ; Howarth, D; Lowe, GDO; Martin, J; (2002) A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen. THROMB HAEMOSTASIS , 87 (6) 997 - 1005.

Mackie, IJ; Lawrie, AS; Purdy, G; Williams, T; Machin, SJ; (2002) DX-88, a novel Kunitz-type inhibitor of human plasma kallikrein with potential therapeutic use. In: BLOOD. (pp. 88B - 89B). AMER SOC HEMATOLOGY

Mackie, J; Lawrie, AS; Kitchen, S; Gaffney, PJ; Howarth, D; Lowe, GDO; Martin, J; (2002) A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen. Thromb Haemost , 87 (6) pp. 997-1005.

Mackinnon, S; (2002) Alemtuzumab and reduced intensity conditioning. BLOOD , 100 (4) 1508 - 1509.

Madsen, E; Summerville, K; Price, C; Toth, J; Hudson, S; Kiakos, K; Hartley, J; (2002) Molecular recognition of DNA sequence-specific alkylation by conjugates of hairpin polyamide-duocarmycin analogs. ABSTR PAP AM CHEM S , 223 A106 - A106.

Makris, A; Burcombe, RJ; Wilson, GD; Richman, PI; Allen, S; Wright, D; Pittam, M; (2002) Comparison of clinical, radiological and pathological assessment of response to neoadjuvant chemotherapy for primary breast cancer. European Journal of Cancer , 38 268-.

Manderson, EN; Presneau, N; Provencher, D; Mes-Masson, AM; Tonin, PN; (2002) Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. MOL CARCINOGEN , 34 (2) 78 - 90. 10.1002/mc.10051.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update August 2001. Tissue Antigens , 59 (1) pp. 73-74.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update September 2001. Tissue Antigens , 59 (1) pp. 75-76.

Marsh, SGE; (2002) Nomenclature for factors of the HLA System, update September 2001. Eur J Immunogenet , 29 (1) 79-.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update April 2002. Eur J Immunogenet , 29 (5) pp. 457-458.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update December 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (2) p. 117. 10.1046/j.1365-2370.2002.00317.x.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update February 2002. Eur J Immunogenet , 29 (3) 277-.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update January 2002. Eur J Immunogenet , 29 (3) 275-.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update June 2002. Eur J Immunogenet , 29 (5) 461-.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update March 2002. Eur J Immunogenet , 29 (3) pp. 279-280.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update May 2002. Eur J Immunogenet , 29 (5) 459-.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update November 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (2) p. 115. 10.1046/j.1365-2370.2002.00316.x.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update October 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (2) p. 113. 10.1046/j.1365-2370.2002.00315.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; (2002) Nomenclature for factors of the HLA system, 2002. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (6) pp. 463-516. 10.1046/j.1365-2370.2002.00359.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; (2002) Nomenclature for factors of the HLA system, 2002. Tissue Antigens , 60 (5) pp. 407-464.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; (2002) Nomenclature for factors of the HLA system, 2002. Hum Immunol , 63 (12) pp. 1213-1268.

Marsh, SGE; WHO Nomemclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update December 2001. Tissue Antigens , 59 (2) pp. 172-173.

Marsh, SGE; WHO Nomemclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update November 2001. Tissue Antigens , 59 (2) pp. 170-171.

Marsh, SGE; WHO Nomemclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update October 2001. Tissue Antigens , 59 (2) pp. 168-169.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update April 2002. Hum Immunol , 63 (9) pp. 795-796.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update February 2002. Hum Immunol , 63 (6) 514-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update March 2002. Hum Immunol , 63 (6) pp. 515-516.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, updated May 2002. Hum Immunol , 63 (10) 966-.

Marsh, SGE; Who Nomenclature Committee for Factor of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update February 2002. Tissue Antigens , 59 (3) pp. 237-238.

Marsh, SGE; Who Nomenclature Committee for Factor of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update January 2002. Tissue Antigens , 59 (3) pp. 235-236.

Marsh, SGE; Who Nomenclature Committee for Factor of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update March 2002. Tissue Antigens , 59 (3) pp. 239-240.

Marzolini, MAV; Wynne, H; (2002) Should patients manage their own oral anticoagulation therapy? Reviews in Clinical Gerontology , 12 (4) pp. 275-281.

Mateos, A; Herrero, J; Dopazo, J; (2002) Using perceptrons for supervised classification of DNA microarray samples: Obtaining the optimal level of information and finding differentially expressed genes. In: Dorronsoro, JR, (ed.) (Proceedings) 12th International Conference on Artifical Neural Networks (ICANN 2002). (pp. pp. 577-582). SPRINGER-VERLAG BERLIN

Maughan, TS; James, RD; Kerr, DJ; Ledermann, JA; McArdle, C; Seymour, MT; Cohen, D; (2002) Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. LANCET , 359 (9317) 1555 - 1563.

Mayer, A; Spencer, DIR; Tolner, B; Purdy, D; Begent, RHJ; Chester, K; (2002) A recombinant fusion protein with potentially reduced immunogenicity for ADEPT. British Journal of Cancer , 86 S117-S117.

Mayer, A; Spencer, DIR; Tolner, B; Purdy, D; Begent, RHJ; Chester, K; (2002) A recombinant fusion protein with potentially reduced immunogenicity for ADEPT. BRIT J CANCER , 86 S117 - S117.

McHugh, PJ; Kiakos, K; Hartley, JA; Lee, M; (2002) The Rad6 pathway is involved in the nucleotide excision repair of DNA minor groove adducts. In: (pp. 5103-).

McIlhatton, BP; Keating, C; Curran, MD; McMullin, MF; Barr, JG; Madrigal, JA; Middleton, D; (2002) Identification of medically important pathogenic fungi by reference strand-mediated conformational analysis (RSCA). J MED MICROBIOL , 51 (6) pp. 468-478.

Mehta, A; (2002) Agalsidase alfa: specific treatment for Fabry disease. Hospital Medicine , 63 (6) pp. 347-350.

Mehta, A; (2002) New developments in the management of Anderson-Fabry disease. QJM , 95 pp. 647-653.

Mezzina, M; Danos, O; (2002) Five years of vector service for gene therapy. Trends Genet , 18 (3) pp. 118-119.

Migliorini, D; Danovi, D; Colombo, E; Carbone, R; Pelicci, PG; Marine, JC; (2002) Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation. J BIOL CHEM , 277 (9) 7318 - 7323. 10.1074/jbc.M108795200. Gold open access

Migliorini, D; Denchi, EL; Danovi, D; Jochemsen, A; Capillo, M; Gobbi, A; Helin, K; (2002) Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. MOL CELL BIOL , 22 (15) 5527 - 5538. 10.1128/MCB.22.15.5527-5538.2002.

Mills, KI; Gilkes, AF; Linch, DC; Burnett, AK; (2002) Risk group stratification in AML by the use of micro-arrays. In: BLOOD. (pp. 744A - 744A). AMER SOC HEMATOLOGY

Monastiri, K; Ben Ahmed, S; Presneau, N; Bignon, JY; Chouchane, L; (2002) [Rapid detection of BRCA-1 germline mutations by the protein truncation test in Tunisian families]. Tunis Med , 80 (9) pp. 515-518.

Morris, E; Thomson, K; Craddock, C; Milligan, D; Smith, GM; Parker, A; Schey, S; (2002) Long-term follow-up of an alemtuzumab (CAMPATH-1H) containing reduced intensity allogeneic transplant regimen for non-Hodgkin's lymphoma (NHL). In: BLOOD. (pp. 40A - 40A). AMER SOC HEMATOLOGY

Mortuza, FY; Papaioannou, M; Moreira, IM; Coyle, LA; Gameiro, P; Gandini, D; Prentice, HG; (2002) Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia. Journal of Clinical Oncology , 20 (4) pp. 1094-1104.

Mushipe, MT; Revell, PA; Shelton, JC; (2002) Cancellous bone repair using bovine trabecular bone matrix particulates. Biomaterials , 23 (2) pp. 365-370. 10.1016/S0142-9612(01)00114-4.

Mushipe, MT; Revell, PA; Shelton, JC; (2002) The effects of bovine trabecular bone matrix particulates on cortical bone repair. Journal of Materials Science: Materials in Medicine , 13 (1) pp. 99-105.

N

Nacheva, EP; Reid, AG; Tarpey, PS; Grace, CD; (2002) Quantification of locus copy number in chronic myeloid leukaemia using multiplex amplifiable probe hybridisation (MAPH). In: BLOOD. (pp. 325B - 325B). AMER SOC HEMATOLOGY

Naik, P; Morris, E; Mackinnon, S; Singer, M; (2002) Do critically ill patients with haematological malignancy survive intensive care and beyond? BRIT J ANAESTH , 89 (2) 359P - 359P.

Nakahara, T; Yaguchi, H; Yoshida, M; Miyakoshi, J; (2002) Effects of exposure of CHO-K1 cells to a 10-T static magnetic field. Radiology , 224 (3) pp. 817-822. 10.1148/radiol.2243011300.

Nash, M; Cohen, H; (2002) Antiphospholipid syndrome. Medicine , 30 pp. 31-32.

Nash, M; Cohen, H; (2002) Disorders of thrombosis and haemostasis. Surgery , 30 pp. 203-208.

Nathwani, A; Davidoff, AM; Hanawa, H; Hu, Y; Hoffer, FA; Nikanorov, A; Slaughter, C; (2002) Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood , 100 (5) pp. 1662-1669. 10.1182/blood-2002-02-0589. Green open access
file

Nehls, O; Klump, B; Arkenau, HT; Hass, HG; Greschniok, A; Gregor, M; Porschen, R; (2002) Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial. Br J Cancer , 87 (7) pp. 702-704. 10.1038/sj.bjc.6600543.

Newton, R; Ziegler, J; Ateenyi-Agaba, C; Bousarghin, L; Casabonne, D; Beral, V; Mbidde, E; (2002) The epidemiology of conjunctival squamous cell carcinoma in Uganda. BRIT J CANCER , 87 (3) 301 - 308. 10.1038/sj.bjc.6600451.

Nicholson, PW; Harland, SJ; (2002) Survival prospects after screen-detection of prostate cancer. BJU INT , 90 (7) 686 - 693. 10.1046/j.1464-4096.2002.03005.x.

Nikitenko, LL; Smith, DM; Hague, S; Wilson, CR; Bicknell, R; Rees, MCP; (2002) Adrenomedullin and the microvasculature. TRENDS PHARMACOL SCI , 23 (3) 101 - 103.

Nimmo, R; Woollard, A; (2002) Widespread organisation of C-elegans genes into operons: fact or function? BIOESSAYS , 24 (11) pp. 983-987. 10.1002/bies.10181.

Niyikiza, C; Baker, SD; Seitz, DE; Walling, JM; Nelson, K; Rusthoven, JJ; Stabler, SP; (2002) Homocysteine and methylmalonic acid: Markers to predict and avoid toxicity from pemetrexed therapy. MOL CANCER THER , 1 (7) 545 - 552.

Niyikiza, C; Hanauske, AR; Rusthoven, JJ; Calvert, AH; Allen, R; Paoletti, P; Bunn, PA; (2002) Pemetrexed safety and dosing strategy. SEMIN ONCOL , 29 (6) 24 - 29. 10.1053/sonc.2002.37465.

Nnene, IO; Nieto, JJ; Rolfe, KJ; Crow, JC; Sundaresan, M; MacLean, AB; Perrett, CW; (2002) P53 expression in ovarian epithelial dysplasia. In:

Novik, KL; Nimmrich, I; Genc, B; Maier, S; Piepenbrock, C; Olek, A; Beck, S; (2002) Epigenomics: genome-wide study of methylation phenomena. Curr Issues Mol Biol , 4 (4) pp. 111-128. Gold open access

O

O'Hare, CC; Mack, D; Tandon, M; Sharma, SK; Lown, JW; Kopka, ML; Dickerson, RE; (2002) DNA sequence recognition in the minor groove by crosslinked polyamides: The effect of N-terminal head group and linker length on binding affinity and specificity. P NATL ACAD SCI USA , 99 (1) 72 - 77.

Oakley, TJ; Goodwin, A; Chakraverty, RK; Hickson, ID; (2002) Inactivation of homologous recombination suppresses defects in topoisomerase III-deficient mutants. DNA Repair (Amst) , 1 (6) pp. 463-482.

Ohkura, N; Yaguchi, H; Tsukada, T; Yamaguchi, K; (2002) The EWS/NOR1 fusion gene product gains a novel activity affecting pre-mRNA splicing. J Biol Chem , 277 (1) pp. 535-543. 10.1074/jbc.M109018200. Gold open access

Okkenhaug, K; Bilancio, A; Farjot, G; Priddle, H; Sancho, S; Peskett, E; Pearce, W; (2002) Impaired B and T cell antigen receptor signaling in p110 delta PI 3-kinase mutant mice. SCIENCE , 297 (5583) pp. 1031-1034.

Oksenhendler, E; Boulanger, E; Galicier, L; Du, MQ; Dupin, N; Diss, TC; Hamoudi, R; (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. BLOOD , 99 (7) pp. 2331-2336.

Oksenhendler, E; Boulanger, E; Galicier, L; Du, MQ; Dupin, N; Diss, TC; Hamoudi, R; (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. BLOOD , 99 (7) 2331 - 2336.

Oksenhendler, E; Boulanger, E; Galicier, L; Du, MQ; Dupin, N; Diss, TC; Hamoudi, RA; (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood , 99 (7) pp. 2331-2336.

Orchard, K; Barrington, S; Buscombe, J; Hilson, A; Prentice, HG; Mehta, A; (2002) Fluoro-deoxyglucose positron emission tomography imaging for the detection of occult disease in multiple myeloma. British Journal of Haematology , 117 (1) pp. 133-135.

P

PORTER, J; DAVIS, B; (2002) Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. Best Practice & Research Clinical Haematology , 15 (2) pp. 329-368. 10.1053/beha.2002.0214.

Panaretou, B; Siligardi, G; Meyer, P; Maloney, A; Sullivan, JK; Singh, S; Millson, SH; (2002) Activation of the ATPase activity of Hsp90 by the stress-regulated cochaperone Aha1. MOLECULAR CELL , 10 (6) pp. 1307-1318. 10.1016/S1097-2765(02)00785-2.

Parmar, MKB; Adams, M; Balestrino, M; Bertelsen, K; Bonazzi, C; Calvert, H; Colombo, N; (2002) Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. LANCET , 360 (9332) 505 - 515.

Parsons, MJ; Pollard, SM; Saúde, L; Feldman, B; Coutinho, P; Hirst, EMA; Stemple, DL; (2002) Zebrafish mutants identify an essential role for laminins in notochord formation. Development , 129 (13) pp. 3137-3146.

Patel, K; Stein, R; Benvenuti, S; Zvelebil, MJ; (2002) Combinatorial use of mRNA and two-dimensional electrophoresis expression data to choose relevant features for mass spectrometric identification. PROTEOMICS , 2 (10) pp. 1464-1473. 10.1002/1615-9861(200210)2:10<1464::AID-PROT1464>3.0.CO;2-9.

Patel, N; Best, SM; Bonfield, W; Gibson, IR; Hing, KA; Damien, E; Revell, PA; (2002) A comparative study on the in vivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules. Journal of Materials Science: Materials in Medicine , 13 (12) pp. 1199-1206.

Patel, N; Gibson, IR; Hing, KA; Best, SM; Damien, E; Revell, PA; Bonfield, W; (2002) The in vivo response of phase pure hydroxyapatite and carbonate substituted hydroxyapatite granules of varying size ranges. UNSPECIFIED

Patel, Y; Moraes, YC; Latchman, D; Coffin, R; de Belleroche, J; (2002) Neuroprotective effects of copper/zinc-dependent superoxide dismutase against a wide variety of death-inducing stimuli and proapoptotic effect of familial amyotrophic lateral sclerosis mutations. MOL BRAIN RES , 109 (1-2) 189 - 197.

Paul, MJ; Summers, Y; Calvert, AH; Rustin, G; Brampton, MH; Thatcher, N; Middleton, MR; (2002) Effect of temozolomide on central nervous system relapse in patients with advanced melanoma. MELANOMA RES , 12 (2) 175 - 178.

Payne, EM; Gerrard, G; Ganeshaguru, K; McCullough, H; Ethell, M; Potter, M; Prentice, HG; (2002) A phase 1 study of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) in combination with daunorubicin and cytarabine in adult acute myeloid leukemia. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 557A-557A). AMER SOC HEMATOLOGY

Pedley, RB; El-Emir, E; Flynn, AA; Boxer, GM; Dearling, J; Raleigh, JA; Hill, SA; (2002) Synergy between vascular targeting agents and antibody-directed therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , 54 (5) 1524 - 1531.

Peggs, K; (2002) Donor lymphocyte infusion following reduced intensity allografting. In: BONE MARROW TRANSPLANTATION. (pp. S37 - S38). NATURE PUBLISHING GROUP

Peggs, K; Verfuerth, S; Pizzey, A; Ainsworth, J; Moss, P; Mackinnon, S; (2002) Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. BLOOD , 99 (1) 213 - 223.

Peggs, K; Verfuerth, S; Pizzey, A; Ainsworth, J; Moss, P; Mackinnon, S; (2002) Characterization of human cytomegalovirus peptide-specific CD8+ T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. Blood , 99 (1) pp. 213-223. 10.1182/blood.V99.1.213. Green open access
file

Peggs, KS; Mackinnon, S; (2002) Adoptive cellular therapy: a therapeutic reality? Hematology , 7 (3) pp. 127-136. 10.1080/1024533021000013915.

Peggs, KS; Mackinnon, S; (2002) Clinical trials with CMV-specific T cells. CYTOTHERAPY , 4 (1) 21 - 28.

Peggs, KS; Mackinnon, S; Yong, K; (2002) Reduced intensity conditioning and allogeneic stem-cell transplantation: Determining its role in multiple myeloma. J CLIN ONCOL , 20 (20) 4268 - 4268.

Peggs, KS; Morris, EC; Kottaridis, PD; Geary, J; Goldstone, AH; Linch, DC; Mackinnon, S; (2002) Conditioning regimen may influence outcome of ABO incompatible non-myeloablative haemtopoietic allogeneic stem cell transplantation. Blood , 99 pp. 4642-4644.

Peggs, KS; Morris, EC; Kottaridis, PD; Geary, J; Goldstone, AH; Linch, DC; Mackinnon, S; (2002) Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen. BLOOD , 99 (12) 4642 - 4643.

Peggs, KS; Paneesha, S; Kottaridis, PD; Chakraverty, RK; Tobias, G; Reilly, M; Mahendra, P; (2002) Peripheral blood stem cell transplantation for POEMS syndrome. BONE MARROW TRANSPLANTATION , 30 (6) pp. 401-404. 10.1038/sj.bmt.1703670.

Peggs, KS; Thomson, K; Geary, J; Morris, E; Kottaridis, P; Watts, M; Yong, K; (2002) Dose escalating donor lymphocyte infusions (DLI) following T-depleted reduced intensity allografting: High response rates associated with conversion to full donor chimerism (FDC) are not durable despite persistent donor chimerism. In: BLOOD. (pp. 177A - 177A). AMER SOC HEMATOLOGY

Peltékian, E; Garcia, L; Danos, O; (2002) Neurotropism and retrograde axonal transport of a canine adenoviral vector: a tool for targeting key structures undergoing neurodegenerative processes. Mol Ther , 5 (1) pp. 25-32. 10.1006/mthe.2001.0517.

Pemberton, PL; Down, JF; Porter, JB; Bromley, LM; (2002) A retrospective observational study of pre-operative sickle cell screening. ANAESTHESIA , 57 (4) 334 - 337.

Perera, D; Pizzey, A; Campbell, A; Katz, M; Porter, J; Petrou, M; Irvine, DS; (2002) Sperm DNA damage in potentially fertile homozygous beta-thalassaemia patients with iron overload. HUM REPROD , 17 (7) 1820 - 1825.

Perez, N; Plence, P; Millet, V; Greuet, D; Minot, C; Noel, D; Danos, O; (2002) Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. Hum Gene Ther , 13 (18) pp. 2161-2172. 10.1089/104303402320987851.

Perez-Rodriguez, M; Arguello, JR; Fischer, G; Corell, A; Cox, ST; Robinson, J; Hossain, E; (2002) Further polymorphism of the MICA gene. European Journal of Immunogenetics , 29 (1) pp. 35-46.

Perez-Rodriguez, M; Arguello, JR; Fischer, G; Corell, A; Cox, ST; Robinson, J; Hossain, E; (2002) Further polymorphism of the MICA gene. EUR J IMMUNOGEN , 29 (1) pp. 35-46.

Perez-Rodriguez, M; Arguello, JR; Fischer, G; Corell, A; Cox, ST; Robinson, J; Hossain, E; (2002) Further polymorphism of the MICA gene. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (1) pp. 35-46. 10.1046/j.0960-7420.2001.00275.x.

Perez-Rodriguez, M; Madrigal, JA; Marsh, SGE; (2002) A novel HLA-DQA1 allele, DQA1*01042. TISSUE ANTIGENS , 59 (5) pp. 440-442. 10.1034/j.1399-0039.2002.590516.x.

Perez-Rodriguez, M; Raimondi, E; Marsh, SGE; Madrigal, JA; (2002) Identification of a new MICA allele, MICA*047. TISSUE ANTIGENS , 59 (3) pp. 216-218. 10.1034/j.1399-0039.2002.590306.x.

Perez-Simon, JA; Kottaridis, PD; Martino, R; Craddock, C; Caballero, D; Chopra, R; Garcia-Conde, J; (2002) Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders. BLOOD , 100 (9) 3121 - 3127. 10.1182/blood-2002-03-0701.

Peters, GJ; Backus, HHJ; Freemantle, S; van Triest, B; Codacci-Pisanelli, G; van der Wilt, CL; Smid, K; (2002) Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE , 1587 (2-3) 194 - 205.

Petrie, IA; Flynn, AA; Pedley, RB; Green, AJ; El-Emir, E; Dearling, J; Boxer, GM; (2002) The spatial accuracy of 3D reconstructed radioluminographs on serial tissue sections and the resultant absorbed dose estimates. Physics in Medicine and Biology , 47 pp. 3651-3661.

Petrie, IA; Flynn, AA; Pedley, RB; Green, AJ; El-Emir, E; Dearling, JLJ; Boxer, GM; (2002) Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimates. Physics in Medicine and Biology , 47 (20) pp. 3651-3661. 10.1088/0031-9155/47/20/307.

Petrie, IA; Flynn, AA; Pedley, RB; Green, AJ; El-Emir, E; Dearling, JLJ; Boxer, GM; (2002) Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimates. PHYS MED BIOL , 47 (20) 3651 - 3661.

Pickard, D; Bigio, IJ; Bown, SG; Lovat, LB; Ripley, PM; Novelli, M; (2002) Optical biopsy for the diagnosis of dysplasia in Barrett's oesophagus. OPTICAL BIOPSY IV , 4613 234 - 243.

Pietersen, AAM; Tolboom, TCA; Zhang, YH; van Dijk, L; Henriquez, NV; Noteborn, MHM; Huizinga, TWJ; (2002) Fibroblast-like synoviocytes from RA patients exploit a tumor-specific apoptosis pathway whereas synoviocytes from controls do not. In: ARTHRITIS AND RHEUMATISM. (pp. S137 - S137). WILEY-LISS

Pileri, SA; Ascani, S; Zinzani, PL; Gaidano, G; Piccioli, M; Rossi, M; Piccaluga, PP; (2002) Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomach. Haematologica , 87 (12) ECR40-. Gold open access

Pileri, SA; Dirnhofer, S; Went, P; Ascani, S; Sabattini, E; Marafioti, T; Tzankov, A; (2002) Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification. Histopathology , 41 (6) pp. 482-509.

Pileri, SA; Grogan, TM; Harris, NL; Banks, P; Campo, E; Chan, JKC; Favera, RD; (2002) Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology , 41 (1) pp. 1-29.

Pinto, M; (2002) Induction and rejoining of DNA double-strand breaks in human cells after exposure to ionising radiation: an experimental and modelling approach. Doctoral thesis, University of London. Green open access
file

Platt, G; Carbone, A; Mittnacht, S; (2002) p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma. Oncogene , 21 (12) pp. 1823-1831. 10.1038/sj.onc.1205360.

Plemper, RK; Hammond, AL; Gerlier, D; Fielding, AK; Cattaneo, R; (2002) Strength of envelope protein interaction modulates cytopathicity of measles virus. JOURNAL OF VIROLOGY , 76 (10) pp. 5051-5061. 10.1128/JVI.76.10.5051-5061.2002.

Plummer, R; Ghielmini, M; Calvert, P; Voi, M; Renard, J; Gallant, G; Gupta, E; (2002) Phase I and pharmacokinetic study of the new taxane analog BMS-184476 given weekly in patients with advanced malignancies. CLIN CANCER RES , 8 (9) 2788 - 2797.

Porter, JB; Davis, BA; (2002) Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. BEST PRACT RES CL HA , 15 (2) 329 - 368. 10.1053/beha.2002.0214.

Pule, M; Gullmann, C; Dennis, D; McMahon, C; Jeffers, M; Smith, OP; (2002) Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance. British Journal of Haematology , 118 (4) pp. 991-998.

Purnell, B; Howard, T; Lingerfelt, B; McNulty, L; Handl, H; Summerville, K; Hudson, S; (2002) Novel seco-iso-CFI and seco-CFQ analogs of the duocarmycins: Design, synthesis and biological evaluation. ABSTR PAP AM CHEM S , 223 B133 - B133.

Purnell, B; Lingerfelt, B; Scott, A; Summerville, K; Hudson, S; Kiakos, K; Hartley, J; (2002) Novel (S)-(+)- and (R)-(-)-seco-iso-CFI analogs of duocarmycin C2. ABSTR PAP AM CHEM S , 223 B133 - B133.

Q

Quaglia, A; Dhillon, A; Godfrey, A; Laurent, C; Saini, J; Matull, R; Colombari, R; (2002) Degree of genomic heterogeneity correlates with a hepatocellular carcinoma (HCC) histological scoring system for HCC and putative precursor nodular lesions in cirrhotic livers. In: J HEPATOL. (pp. 217 - 218). ELSEVIER SCIENCE BV

Quaglia, A; Dhillon, A; Godfrey, A; Laurent, C; Saini, J; Matull, R; Colombari, R; (2002) Degree of genomic heterogeneity correlates with a hepatocellular carcinoma (HCC) histological scoring system for HCC and putative precursor nodular lesions in cirrhotic livers. Journal of Hepatology , 36 776-.

Quaglia, A; Laurent, C; Girlando, S; Saini, J; Dalla Palma, P; Colombari, R; Bioulac-Sage, P; (2002) Clonality and genomic heterogeneity in HCC and putative precursor nodular lesions. J HEPATOL , 36 83 - 83.

Quarmby, JW; Engelke, C; Chitolie, A; Morgan, RA; Belli, AM; (2002) Autologous thrombin for treatment of pseudoaneurysms. LANCET , 359 (9310) 946 - 947.

R

Radosavljevic, M; Cuillerier, B; Wilson, MJ; Clement, O; Wicker, S; Gilfillan, S; Beck, S; (2002) A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. GENOMICS , 79 (1) 114 - 123. 10.1006/geno.2001.6673.

Ramon, D; Corell, A; Cox, ST; Soteriou, B; Madrigal, JA; Marsh, SGE; (2002) Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041 alleles. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (5) pp. 453-455. 10.1046/j.1365-2370.2002.00354.x.

Ravichandran, D; Shenoy, V; Kocjan, G; Ball, RY; Ralphs, DNL; (2002) Touch imprint cytology in the assessment of sentinel lymph node status. EUR J CANCER , 38 S61 - S61.

Reddy, A; Yuille, M; Sullivan, A; Repellin, C; Bell, A; Tidy, JA; Evans, DJ; (2002) Analysis of CHK2 in vulval neoplasia. Br J Cancer , 86 (5) pp. 756-760. 10.1038/sj.bjc.6600131.

Reid, AG; Huntly, BJP; Hennig, E; Niederwieser, D; Campbell, LJ; Bown, N; Telford, N; (2002) Deletions of the derivative chromosome 9 do not account for the poor prognosis associated with Philadelphia-positive acute lymphoblastic leukemia. In: BLOOD. (pp. 2274 - 2275). AMER SOC HEMATOLOGY

Rew, SB; Lopes, L; Peggs, K; Koishihara, Y; Kosaka, M; Ozaki, S; Chain, B; (2002) Generation of T-cell mediated immune responses to the myeloma antigen, HM1.24. In: BLOOD. (pp. 105A - 105A). AMER SOC HEMATOLOGY

Robinson, SP; Sureda, A; Mackinnon, S; Carella, A; Taghipour, G; Goldstone, AH; Schmitz, N; (2002) Reduced intensity allogeneic stem cell transplantation for Hodgkin's disease: An analysis from the European group for Blood and Marrow Transplantation. In: BLOOD. (pp. 144A - 144A). AMER SOC HEMATOLOGY

Rohn, JL; Zhang, Y-H; Aalbers, RIJM; Otto, N; Den Hertog, J; Henriquez, NV; Van De Velde, CJH; (2002) A tumor-specific kinase activity regulates the viral death protein Apoptin. J Biol Chem , 277 (52) pp. 50820-50827. 10.1074/jbc.M208557200. Gold open access

Rojas, A; Saunders, MI; (2002) ARCON in clinical radiotherapy. In: Kogelnik, HD and Lukas, P and Sedlmayer, F, (eds.) Progress in Radio-oncology. (pp. 89-98).

Rojas, A; Saunders, MI; (2002) Addition of chemotherapy to altered fractionation schedules in non-small cell lung cancer. In: Kogelnik, HD and Lukas, P and Sedlmayer, F, (eds.) Progress in Radio-oncology VII. (pp. 437-445). Monduzzi

Rolfe, KJ; Crow, JC; Reid, WMN; Benjamin, E; MacLean, AB; Perrett, CW; (2002) The effect of topical corticosteroids on Ki67 and p53 expression in vulval lichen sclerosus. BRIT J DERMATOL , 147 (3) 503 - 508.

Rooney, CM; Bollard, C; Huls, MH; Gahn, B; Gottschalk, S; Wagner, HJ; Anderson, R; (2002) Immunotherapy for Hodgkin's disease. Annals of Hematology , 81 S39-S42.

Rosti, G; Ferrante, P; Ledermann, J; Leyvraz, S; Ladenstein, R; Koscileniak, E; Crown, J; (2002) High-dose chemotherapy for solid tumors: results of the EBMT. Crit Rev Oncol Hematol , 41 (2) pp. 129-140.

Rowntree, C; Duke, V; Panayiotidis, P; Kotsi, P; Palmisano, GL; Hoffbrand, AV; Foroni, L; (2002) Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia. LEUKEMIA , 16 (7) pp. 1267-1275. 10.1038/sj.leu.2402551.

Rudd, RM; Gower, NH; James, LE; Gregory, W; Eisen, T; Lee, SM; Harper, PG; (2002) Phase III randomised comparison of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC). In: (pp. 1164-).

Rudd, RM; Gower, NH; James, LE; Gregory, W; Eisen, T; Lee, SM; et, A; (2002) A phase III randomised comparison of gemcitabine/carboplatin with mitomycin/ifosfamide/cisplatin in advanced non-small cell lung cancer. In: (Proceedings) Oral presentation. 2002 Annual ASCO Meeting/38th Annual Meeting, Orlando, FL.. (pp. 1164-). Proceedings of the American Society of Clinical Oncology

Rudnicka, AR; Wald, NJ; Huttly, W; Hackshaw, AK; (2002) Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance. PRENATAL DIAG , 22 (10) 893 - 897. 10.1002/pd.440.

S

Sabin, CA; Emery, V; Devereux, HL; Griffioen, AA; Bishop, J; Dusheiko, G; Yee, TT; (2002) Long-term patterns of hepatitis C virus RNA concentrations in a cohort of HIV seronegative men with bleeding disorders. J MED VIROL , 68 (1) 68 - 75. 10.1002/jmv.10171.

Sabin, CA; Griffioen, A; Yee, TT; Emery, VC; Herrero-Martinez, E; Phillips, AN; Lee, CA; (2002) Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study. LANCET , 360 (9345) 1546 - 1551.

Salim, K; Fenton, T; Bacha, J; Urien-Rodrigu